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SCIENTIFIC OPINION  
Scientific Opinion on Flavouring Group Evaluation 7, Revision 4 
(FGE.07Rev4): 
Saturated and unsaturated aliphatic secondary alcohols, ketones and esters 
of secondary alcohols and saturated linear or branched-chain carboxylic 
acids from chemical group 5
1 
EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
(CEF)
2, 3  
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids of the European Food Safety 
Authority was requested to evaluate 49 flavouring substances in the Flavouring Group Evaluation 07, including 
additional five substances in this Revision 4, using the Procedure in Commission Regulation (EC) No 
1565/2000. Since the publication of the last revision of this FGE, the EFSA has been requested to evaluate five 
additional substances, 2,6-dimethylocta-1,5,7-trien-3-ol, octa-1,5-dien-3-ol, undeca-1,5-dien-3-ol, pseudo-ionone 
and 3,3,6-trimethylhepta-1,5-dien-4-one [FL-no: 02.145, 02.194, 02.211, 07.198 and 07.204], which have been 
included in the present revision of FGE.07. None of the 49 substances were considered to have genotoxic 
potential. The substances were evaluated through a stepwise approach that integrates information on the 
structure-activity relationships, intake from current uses, toxicological threshold of concern, and available data 
on metabolism and toxicity. The Panel concluded that all 49 substances do not give rise to safety concerns at 
their levels of dietary intake, estimated on the basis of the MSDI approach. Besides the safety assessment of the 
flavouring substances, the specifications for the materials of commerce have also been considered. For three 
substances [FL-no: 02.194, 02.211 and 02.255] the stereoisomeric compositions have not been given and for one 
substance [FL-no: 07.156] information on the composition of the stereoisomeric mixture is lacking. 
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SUMMARY  
The European Food Safety Authority (EFSA) asked the Panel on Food Contact Materials, Enzymes, 
Flavourings and Processing Aids (the Panel) to provide scientific advice to the Commission on the 
implications for human health of chemically defined flavouring substances used in or on foodstuffs in 
the Member States. In particular, the Panel was requested to evaluate 49 flavouring substances in the 
Flavouring Group Evaluation 7, Revision 4 (FGE.07Rev4), using the Procedure as referred to in the 
Commission Regulation (EC) No 1565/2000. These 49 flavouring substances belong to chemical 
group 05, Annex I of the Commission Regulation (EC) No 1565/2000. 
The present Revision of FGE.07, FGE.07Rev4, includes the assessment of five additional candidate 
substances [FL-no: 02.145, 02.194, 02.211, 07.198 and 07.204]. These substances have been 
considered with respect to genotoxicity in FGE.206 (EFSA, 2011c) and the Panel concluded that the 
data available ruled out the concern for genotoxicity and thus concluded that the substances can be 
evaluated through the Procedure. 
The 49 candidate substances are saturated and unsaturated aliphatic secondary alcohols, ketones and 
esters of secondary alcohols and saturated linear or branched-chain saturated carboxylic acids from 
chemical group 5. 
Twenty-five candidate substances possess one chiral centre [FL-no: 02.124, 02.142, 02.145, 02.148, 
02.177, 02.183, 02.190, 02.194, 02.211, 02.255, 07.157, 07.182, 07.185, 07.239, 09.304, 09.323, 
09.325, 09.328, 09.332, 09.386, 09.388, 09.391, 09.676, 09.880 and 09.926], and two of the candidate 
substances possess two chiral centres [FL-no: 02.182 and 07.205]. The stereoisomeric compositions 
have not been specified sufficiently for three substances [FL-no: 02.194, 02.211 and 02.255]. 
Due to the presence and the position of double bonds, 10 candidate substances can exist as geometrical 
isomers [FL-no: 02.145, 02.194, 02.211, 02.255, 07.156, 07.198, 07.236, 07.239, 09.386, and 09.880]. 
For one of these [FL-no: 07.156], the stereoisomeric composition has been specified as the E/Z 
mixture, but the composition of the mixture has not been given. 
Twenty-eight candidate substances belong to structural class I, and 21 candidate substances belong to 
structural class II.  
Forty-five of the flavouring substances in the present group of 49 flavouring substances have been 
reported to occur naturally in a wide range of food items. 
In its evaluation, the Panel as a default used the “Maximised Survey-derived Daily Intake” (MSDI) 
approach to estimate the per capita intakes of the flavouring substances in Europe. However, when the 
Panel examined the information provided by the European Flavour Industry on the use levels in 
various foods, it appeared obvious that the MSDI approach in a number of cases would grossly 
underestimate the intake by regular consumers of products flavoured at the use level reported by the 
Industry, especially in those cases where the annual production values were reported to be small. In 
consequence, the Panel had reservations about the data on use and use levels provided and the intake 
estimates obtained by the MSDI approach.  
In the absence of more precise information that would enable the Panel to make a more realistic 
estimate of the intakes of the flavouring substances, the Panel has decided also to perform an estimate 
of the daily intakes per person using a modified “Theoretical Added Maximum Daily Intake” 
(mTAMDI) approach based on the normal use levels reported by Industry. In those cases where the 
mTAMDI approach indicated that the intake of a flavouring substance might exceed its corresponding 
threshold of concern, the Panel decided not to carry out a formal safety assessment using the 
Procedure. In these cases the Panel requires more precise data on use and use levels. Flavouring Group Evaluation 07, Revision 4
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According to the default MSDI approach, 49 candidate substances have European daily per capita 
intakes ranging from 0.0012 to 73 µg, which are below the threshold of concern for structural class I 
and class II substances (1800 and 540 µg/person/day, respectively).  
On the basis of the reported annual production in Europe (MSDI approach), the combined intakes of 
the 28 of the candidate substances belonging to structural class I and of the 21 candidate substances 
belonging to structural class II would result in total intakes of 6 and 77 µg/capita/day, respectively. 
These values are lower than the thresholds of concern for structural class I or class II substances. The 
total combined estimated levels of intake of the candidate and supporting substances is approximately 
340 µg/capita/day (without acetone and isopropanol) for structural class I substances and 1200 
µg/capita/day for structural class II substances. This latter value does exceed the threshold of concern 
for the structural class. However, this level is not expected to saturate the detoxication reactions able 
to biotransform these compounds to innocuous products. 
On the basis of available data from in vitro and in vivo tests on candidate and supporting substances, it 
can be concluded that the 49 candidate substances included in this group exhibit no genotoxic 
potential. 
Forty-eight candidate substances would be expected to be metabolised to innocuous substances at the 
estimated levels of intake as flavouring substances. 
One candidate substance, 5-methylheptan-3-one [FL-no: 07.182], may be oxidised to a potential 
neurotoxic gamma-diketone. However, this metabolic path does not pose a safety concern at the 
estimated level of intake as a flavouring substance. Indeed, for this substance a NOAEL for 
neurotoxicity of 82 mg/kg bw/day was established in a subchronic study on adult male rats dosed with 
0, 82, 410 and 820 mg/kg bw/day for 13 weeks. This NOAEL provides a margin of safety of 1.5 x 10
7 
based on the estimated intake of the candidate substance of 0.32 µg/capita/day. 
Otherwise it was noted, that where toxicity data were available on single flavouring substances, they 
were consistent with the conclusions in the present FGE using the Procedure.  
It is considered that on the basis of the default MSDI approach none of the 49 candidate substances 
would give rise to safety concerns at the estimated levels of intake arising from their use as flavouring 
substances. 
When the estimated intakes were based on the mTAMDI they ranged from 1600 to 3900 
µg/person/day for the 28 candidate substances from structural class I. The intakes were all above the 
threshold of concern for structural class I of 1800 µg/person/day, except for three flavouring 
substances [FL-no: 07.084, 07.178 and 07.239]. The estimated intakes of the 21 candidate substances 
assigned to structural class II, based on the mTAMDI, range from 1500 to 6600 µg/person/day, which 
are all above the threshold of concern for structural class II of 540 µg/person/day. The three 
substances [FL-no: 07.084, 07.178 and 07.239], which have mTAMDI intake estimates below the 
threshold of concern for the structural class, are also expected to be metabolised to innocuous 
products. 
Thus, for 46 of the 49 candidate substances considered in this Opinion the intakes, estimated on the 
basis of the mTAMDI, exceed the relevant threshold for their structural class, to which the flavouring 
substance has been assigned. Therefore, for these 46 substances more reliable exposure data are 
required. On the basis of such additional data, these flavouring substances should be reconsidered 
along the steps of the Procedure. Following this procedure additional toxicological data might become 
necessary.  
In order to determine whether the conclusion for the 49 candidate substances evaluated through the 
Procedure can be applied to the materials of commerce, it is necessary to consider the available 
specifications. Adequate specifications including purity and identity for the materials of commerce Flavouring Group Evaluation 07, Revision 4
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have been provided for all the candidate substances. The stereoisomeric compositions have not been 
specified for three substances [FL-no: 02.194, 02.211 and 02.255]. For one substance [FL-no: 07.156], 
the stereoisomeric composition has been specified as the E/Z mixture, but the composition of the 
mixture has not been given. Thus, the final evaluation of the materials of commerce cannot be 
performed for these substances, pending further information. 
The remaining 45 substances [FL-no: 02.077, 02.124, 02.142, 02.145, 02.148, 02.177, 02.182, 02.183, 
02.190, 07.072, 07.084, 07.150, 07.157, 07.158, 07.160, 07.162, 07.178, 07.181, 07.182, 07.185, 
07.189, 07.198, 07.199, 07.201, 07.204, 07.205, 07.236, 07.239, 07.262, 09.304, 09.323, 09.325, 
09.328, 09.332, 09.386, 09.388, 09.391, 09.604, 09.605, 09.606, 09.608, 09.609, 09.676, 09.880 and 
09.926] would present no safety concern at the levels of intake estimated on the basis of the MSDI 
approach. 
 Flavouring Group Evaluation 07, Revision 4
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BACKGROUND 
Regulation (EC) No 2232/96 of the European Parliament and the Council (EC, 1996a) lays down a 
Procedure for the establishment of a list of flavouring substances the use of which will be authorised 
to the exclusion of all other substances in the EU. In application of that Regulation, a Register of 
flavouring substances used in or on foodstuffs in the Member States was adopted by Commission 
Decision 1999/217/EC (EC, 1999a), as last amended by Commission Decision 2009/163/EC (EC, 
2009a). Each flavouring substance is attributed a FLAVIS-number (FL-number) and all substances are 
divided into 34 chemical groups. Substances within a group should have some metabolic and 
biological behaviour in common. 
Substances which are listed in the Register are to be evaluated according to the evaluation programme 
laid down in Commission Regulation (EC) No 1565/2000 (EC, 2000a), which is broadly based on the 
Opinion of the Scientific Committee on Food (SCF, 1999a). For the submission of data by the 
manufacturer, deadlines have been established by Commission Regulation (EC) No 622/2002 (EC, 
2002b).  
The FGE is revised to include substances for which data were submitted after the deadline as laid 
down in Commission Regulation (EC) No 622/2002 and to take into account additional information 
that has been made available since the previous Opinion on this FGE.  
The Revision also includes newly notified substances belonging to the same chemical groups 
evaluated in this FGE. 
After the completion of the evaluation programme the Union List of flavouring substances for use in 
or on foods in the EU shall be adopted (Article 5 (1) of Regulation (EC) No 2232/96) (EC, 1996a). 
HISTORY OF THE EVALUATION  
The first version of the Flavouring Group Evaluation 07, FGE.07, dealt with 35 saturated and 
unsaturated aliphatic secondary alcohols, ketones and esters with secondary alcohol moiety. 
The first revision of FGE.07, FGE.07Rev1, included the assessment of six additional flavouring 
substances [FL-no: 02.190, 07.162, 07.201, 07.236, 07.676 and 09.926]. No new data on toxicity were 
provided. For two of the new substances [FL-no: 07.162 and 07.201], data on metabolism were 
provided. Additional information for twenty flavouring substances [FL-no: 02.124, 02.142, 02.148, 
02.177, 02.182, 02.183, 07.156, 07.157, 07.182, 07.185, 07.205, 09.304, 09.323, 09.325, 09.328, 
09.332, 09.386, 09.388, 09.391 and 09.880] were made available since the FGE.07 was published.  
The second Revision of FGE.07, FGE.07Rev2, included the assessment of two additional flavouring 
substances [FL-no: 02.255 and 07.239]. No new data on toxicity and metabolism were provided. 
The third Revision of FGE.07, FGE.07Rev3, included the assessment of one additional candidate 
substance [FL-no: 07.262]. Toxicity data (acute toxicity, 28-days study and an Ames test) were 
submitted. No metabolism data were provided for this substance. A search in open literature did not 
provide any further data on toxicity or metabolism for this substance. Furthermore additional 
information on the specifications for eight candidate substances requested in FGE.07Rev2 was made 
available and included in this FGE. 
FGE  Opinion adopted 
by EFSA 
Link  No. candidate 
substances 
FGE.07  9 December 2004  http://www.efsa.europa.eu/en/scdocs/scdoc/164.htm 35 
FGE.07Rev1  26 September 2007  http://www.efsa.europa.eu/en/scdocs/scdoc/722.htm 41 
FGE.07Rev2  26 March 2009  http://www.efsa.europa.eu/en/scdocs/scdoc/1020.htm 43 
FGE.07Rev3  30 September 2010  http://www.efsa.europa.eu/en/efsajournal/pub/1845.htm 44 
FGE.07Rev4 September  2012    49 Flavouring Group Evaluation 07, Revision 4
 
EFSA Journal 2012;10(10):2899  8
 
The present Revision of FGE.07, FGE.07Rev4, includes the assessment of five additional candidate 
substances [FL-no: 02.145, 02.194, 02.211, 07.198 and 07.204]. These substances have been 
considered with respect to genotoxicity in FGE.206 (EFSA, 2011c) and the Panel concluded that the 
data available ruled out the concern for genotoxicity and thus concluded that the substances can be 
evaluated through the Procedure. A search in open literature was conducted for metabolism, 
genotoxicity and toxicity for these five new substances, and additional information was identified for 
[FL-no: 07.198] which has been included in the present FGE. 
TERMS OF REFERENCE AS PROVIDED BY THE COMMISSION 
The European Food Safety Authority (EFSA) is requested to carry out a risk assessment on flavouring 
substances in the Register (Commission decision 1999/217/EC), according to Commission Regulation 
(EC) No 1565/2000 (EC, 2000a), prior to their authorisation and inclusion in the Union list 
(Regulation (EC) No 1334/2008) (EC, 2008b). The evaluation programme was finalised at the end of 
2009. 
In addition, the Commission requested EFSA, based on additional submitted data on genotoxicity, to 
carry out re-evaluation of five substances, 2,6-dimethylocta-1,5,7-trien-3-ol, octa-1,5-dien-3-ol, 
undeca-1,5-dien-3-ol, pseudo-ionone and 3,3,6-trimethylhepta-1,5-dien-4-one [FL-no: 02.145, 02.194, 
02.211, 07.198 and 07.204], through the Procedure, also according to Commission Regulation (EC) 
No 1565/2000 (EC, 2000a). 
ASSESSMENT 
1.  Presentation of the Substances in Flavouring Group Evaluation 7, Revision 4 
1.1.  Description 
The present Flavouring Group Evaluation 7, Revision 4 (FGE.07Rev4), using the Procedure as 
referred to in the Commission Regulation (EC) 1565/2000 (the Procedure - shown in schematic form 
in Annex I), deals with 49 saturated and unsaturated aliphatic acyclic secondary alcohols, ketones and 
esters with a secondary alcohol moiety. These 49 flavouring substances belong to the chemical group 
5 of Annex I of Commission Regulation (EC) No 1565/2000 (EC, 2000a). 
The 49 flavouring substances (candidate substances) are closely related to 58 flavouring substances 
(supporting substances) evaluated at the 51
st, 59
th and 69
th meetings of the Joint FAO/WHO Expert 
Committee on Food Additives (the JEFCA) in the group “Saturated Aliphatic Acyclic Secondary 
Alcohols, Ketones, and Related Saturated and Unsaturated Esters” (JECFA, 2000a; JECFA, 2002c; 
JECFA, 2009c).  
The 49 candidate substances under consideration in the present evaluation are listed in Table 1, as well 
as their chemical Register names, FLAVIS- (FL-), Chemical Abstract Service- (CAS-), Council of 
Europe- (CoE-) and Flavor and Extract Manufacturers Association- (FEMA-) numbers, and structures. 
Seven flavouring substances are saturated aliphatic acyclic secondary alcohols [FL-no: 02.077, 
02.142, 02.148, 02.177, 02.182, 02.183 and 02.190]; five are unsaturated aliphatic secondary alcohols 
[FL-no: 02.124, 02.145, 02.194, 02.211 and 02.255] of which three contain a terminal double bond 
[FL-no: 02.145, 02.194 and 02.211]; 13 are saturated aliphatic ketones [FL-no: 07.072, 07.084, 
07.150, 07.157, 07.158, 07.160, 07.178, 07.181, 07.182, 07.185, 07.189, 07.199 and 07.205]; eight are 
unsaturated aliphatic ketones [FL-no: 07.156, 07.162, 07.198, 07.201, 07.204, 07.236, 07.239 and 
07.262] of which five contain a terminal double bond [FL-no: 07.162, 07.201, 07.204, 07.239 and 
07.262] and 16 are esters of aliphatic acyclic secondary alcohols and linear or branched chain aliphatic 
carboxylic acids [FL-no: 09.304, 09.323, 09.325, 09.328, 09.332, 09.386, 09.388, 09.391, 09.604, 
09.605, 09.606, 09.608, 09.609, 09.676, 09.880 and 09.926]. Flavouring Group Evaluation 07, Revision 4
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The hydrolysis products of the candidate esters are listed in Table 2b. 
The names and structures of the 58 supporting substances are listed in Table 3, together with their 
evaluation status (CoE, 1992; SCF, 1995; JECFA, 2000a; JECFA, 2002c; 2009c). 
1.2.  Stereoisomers 
It is recognised that geometrical and optical isomers of substances may have different properties. Their 
flavour may be different, they may have different chemical properties resulting in possible variability 
in their absorption, distribution, metabolism, elimination and toxicity. Thus, information must be 
provided on the configuration of the flavouring substance, i.e. whether it is one of the 
geometrical/optical isomers, or a defined mixture of stereoisomers. The available specifications of 
purity will be considered in order to determine whether the safety evaluation carried out for candidate 
substances for which stereoisomers may exist can be applied to the material of commerce. Flavouring 
substances with different configurations should have individual chemical names and codes (CAS 
number, FLAVIS number etc.). 
Twenty-five candidate substances possess a chiral centre [FL-no: 02.124, 02.142, 02.145, 02.148, 
02.177, 02.183, 02.190, 02.194, 02.211, 02.255, 07.157, 07.182, 07.185, 07.239, 09.304, 09.323, 
09.325, 09.328, 09.332, 09.386, 09.388, 09.391, 09.676, 09.880 and 09.926] and two of the candidate 
substances possess two chiral centres [FL-no: 02.182 and 07.205]. The stereoisomeric compositions of 
optical isomers have not been specified sufficiently for three substances [FL-no: 02.194, 02.211 and 
02.255] (EFFA, 2012c) (see Table 1). 
Due to the presence and the position of double bonds, 10 candidate substances can exist as geometrical 
isomers [FL-no: 02.145, 02.194, 02.211, 02.255, 07.156, 07.198, 07.236, 07.239, 09.386 and 09.880]. 
For one of these [FL-no: 07.156], the stereoisomeric composition has been specified as the E/Z 
mixture, but the composition of the mixture has not been given (EFFA, 2010a) (see Table 1). 
1.3.  Natural Occurrence in Food 
Forty-five of the candidate substances have been reported to occur naturally. The natural products in 
which these candidate substances are reported to occur mainly are: meat products (chicken, guinea 
fowl), fish and oysters, milk products (butter, milk powder, cheese), fruits (apricot, banana, pineapple, 
guava, mango, grapefruit, cocoa, strawberry, papaya, passion fruit, mushroom, tomato, sweet corn, 
passion flower, green tea), alcoholic beverages (grape brandy, beer, white wine), and/or herbs and 
spices (dill, lemon balm, clove bud, sage, tamarind, tarragon, chamomile) and tea (Flavour Industry, 
2009m; TNO, 2000; TNO, 2012). Quantitative data for the natural occurrence have been reported for 
24 substances in the present Flavouring Group Evaluation. These reports include among others: 
Table 1.3.1 Candidate Substances Reported to Occur in Food  (Flavour Industry, 2009m; TNO, 2012) 
FL-no: Name:  Quantitative data reported 
02.145  2,6-Dimethylocta-1,5,7-trien-3-ol  Up to 100 mg/kg in sage 
02.182  3-Methylpentan-2-ol  0.009 mg/kg in pineapple 
02.194 Octa-1,5-dien-3-ol  0.11-0.15  mg/kg in cheese, various types, up to 
0.05 mg/kg in fish, up to 0.26 mg/kg in oysters 
07.084  Pentan-3-one  Up to 14 mg/kg in different mushroom 
07.160  Heptadecan-2-one  0.1 mg/kg in blue cheese, 1.1 mg/kg in cocoa, 
and 8.7 mg/kg in heated butter 
07.205 6,10,14-Trimethylpentadecan-2-one  2000 mg/kg in lemon balm 
09.323 Sec-butyl  acetate  Up  to 67 mg/kg in vinegar 
09.388  1-Methylhexyl acetate  400 mg/kg in clove bud 
 Flavouring Group Evaluation 07, Revision 4
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According to the TNO the following four substances have not been reported to occur naturally in any 
food items: 
Table 1.3.2 Candidate Substances Not Reported to Occur in Food (TNO, 2000) 
FL-no: Name: 
07.239  R-(E)]-5-Isopropyl-8-methylnona-6,8-dien-2-one 
09.926 Octan-3-yl  formate 
09.332 Sec-butyl  hexanoate 
09.880 4-Hepten-2-yl  butyrate 
 
2.  Specifications 
Purity criteria for all 49 candidate substances have been provided by the Flavour Industry (EFFA, 
2001a; EFFA, 2002b; EFFA, 2002f; EFFA, 2007k; Flavour Industry, 2006p; Flavour Industry, 
2009m). 
Judged against the requirements in Annex II of Commission Regulation (EC) No 1565/2000 (EC, 
2000a), the information is adequate for all candidate substances. Information on stereoisomeric 
composition of optical isomers is missing for three substances [FL-no: 02.194, 02.211 and 02.255] and 
the composition of the mixture of geometrical isomers is missing for one substance [FL-no: 07.156] 
(EFFA, 2010a; EFFA, 2012c) (see Section 1.2 and Table 1).  
3.  Intake Data 
Annual production volumes of the flavouring substances as surveyed by the Industry can be used to 
calculate the “Maximised Survey-derived Daily Intake” (MSDI) by assuming that the production 
figure only represents 60 % of the use in food due to underreporting and that 10 % of the total EU 
population are consumers (SCF, 1999a). 
However, the Panel noted that due to year-to-year variability in production volumes, to uncertainties in 
the underreporting correction factor and to uncertainties in the percentage of consumers, the reliability 
of intake estimates on the basis of the MSDI approach is difficult to assess. 
The Panel also noted that in contrast to the generally low per capita intake figures estimated on the 
basis of this MSDI approach, in some cases the regular consumption of products flavoured at use 
levels reported by the Flavour Industry in the submissions would result in much higher intakes. In 
such cases, the human exposure thresholds below which exposures are not considered to present a 
safety concern might be exceeded. 
Considering that the MSDI model may underestimate the intake of flavouring substances by certain 
groups of consumers, the SCF recommended also taking into account the results of other intake 
assessments (SCF, 1999a). 
One of the alternatives is the “Theoretical Added Maximum Daily Intake” (TAMDI) approach, which 
is calculated on the basis of standard portions and upper use levels (SCF, 1995) for flavourable 
beverages and foods in general, with exceptional levels for particular foods. This method is regarded 
as a conservative estimate of the actual intake by most consumers because it is based on the 
assumption that the consumer regularly eats and drinks several food products containing the same 
flavouring substance at the upper use level. 
One option to modify the TAMDI approach is to base the calculation on normal rather than upper use 
levels of the flavouring substances. This modified approach is less conservative (e.g., it may 
underestimate the intake of consumers being loyal to products flavoured at the maximum use levels 
reported) (EC, 2000a). However, it is considered as a suitable tool to screen and prioritise the 
flavouring substances according to the need for refined intake data (EFSA, 2004a). Flavouring Group Evaluation 07, Revision 4
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3.1.  Estimated Daily per Capita Intake (MSDI Approach) 
The intake estimation is based on the Maximised Survey-derived Daily Intake (MSDI) approach, 
which involves the acquisition of data on the amounts used in food as flavourings (SCF, 1999a). These 
data are derived from surveys on annual production volumes in Europe. These surveys were conducted 
in 1995 by the International Organization of the Flavour Industry, in which flavour manufacturers 
reported the total amount of each flavouring substance incorporated into food sold in the EU during 
the previous year (IOFI, 1995a). The intake approach does not consider the possible natural 
occurrence in food. 
Average per capita intake (MSDI) is estimated on the assumption that the amount added to food is 
consumed by 10 % of the population
4 (Eurostat, 1998). This is derived for candidate substances from 
estimates of annual volume of production provided by Industry and incorporates a correction factor of 
0.6 to allow for incomplete reporting (60 %) in the Industry surveys (SCF, 1999a). 
In the present Flavouring Group Evaluation 7, Revision 4 (FGE.07Rev4) the total annual volume of 
production of the 49 candidate substances for use as flavouring substances in Europe has been 
reported to be approximately 680 kg (EFFA, 2002e; EFFA, 2002f; EFFA, 2007k; Flavour Industry, 
2009m) and for 56 of the 58 supporting substances approximately 750000 kg (isopropyl alcohol 
accounts for 690000 kg and acetone for 50000 kg) (cited by the JECFA (JECFA, 1999a)). For two 
supporting substances no EU annual volume of production are available (JECFA, 2003a). 
On the basis of the annual volumes of production reported for the 49 candidate substances, the daily 
per capita intakes for each of these flavourings have been estimated (Table 2a). Approximately 90 % 
of the total annual volume of production for the candidate substances (EFFA, 2002e; EFFA, 2007k) is 
accounted for by one candidate substance, 9-decen-2-one [FL-no: 07.262]. The estimated daily per 
capita intake of this candidate substance from use as a flavouring substance is 73 µg. The daily per 
capita intakes for the remaining substances is less than 2 µg (Table 2a). 
3.2.  Intake Estimated on the Basis of the Modified TAMDI (mTAMDI) 
The method for calculation of modified Theoretical Added Maximum Daily Intake (mTAMDI) values 
is based on the approach used by SCF up to 1995 (SCF, 1995). 
The assumption is that a person may consume a certain amount of flavourable foods and beverages per 
day. 
For the present evaluation of the 49 candidate substances, information on food categories and normal 
and maximum use levels
5,6,7 were submitted by the Flavour Industry (EFFA, 2002b; EFFA, 2002f; 
EFFA, 2007a; EFFA, 2007b; EFFA, 2007k; Flavour Industry, 2006p; Flavour Industry, 2009m). The 
49 candidate substances are used in flavoured food products divided into the food categories, outlined 
in Annex III of the Commission Regulation (EC) No 1565/2000 (EC, 2000a), as summarised in Table 
3.1. For the present calculation of mTAMDI, the reported normal use levels were used. In the case 
where different use levels were reported for different food categories the highest reported normal use 
level was used. 
                                                      
4 EU figure 375 millions. This figure relates to EU population at the time for which production data are 
available, and is consistent (comparable) with evaluations conducted prior to the enlargement of the EU. No 
production data are available for the enlarged EU. 
5 ”Normal use” is defined as the average of reported usages and ”maximum use” is defined as the 95th percentile 
of reported usages (EFFA, 2002i). 
6 The normal and maximum use levels in different food categories (EC, 2000) have been extrapolated from 
figures derived from 12 model flavouring substances (EFFA, 2004e). 
7 The use levels from food category 5 “Confectionery” have been inserted as default values for food category 
14.2 “Alcoholic beverages” for substances for which no data have been given for food category 14.2 (EFFA, 
2007a). Flavouring Group Evaluation 07, Revision 4
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Table 3.1 Use of in Various Food Categories for 49 Candidate Substances for which Data on Use have 
been provided 
Food 
category 
Description Flavourings  used 
01.0  Dairy products, excluding products of category 2  All  
02.0  Fats and oils, and fat emulsions (type water-in-oil)  All except [FL-no: 
07.262] 
03.0  Edible ices, including sherbet and sorbet  All  
04.1  Processed fruits  All exept [FL-no: 
02.255] 
04.2  Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and 
legumes), and nuts & seeds 
Only [FL-no: 07.262] 
05.0  Confectionery  All except [FL-no: 
07.205] 
06.0  Cereals and cereal products, incl. flours & starches from roots & tubers, pulses 
& legumes, excluding bakery 
All except [FL-no: 
02.255 & 07.262] 
07.0  Bakery wares  All except [FL-no: 
07.262] 
08.0  Meat and meat products, including poultry and game  All except [FL-no: 
02.255 & 07.262] 
09.0  Fish and fish products, including molluscs, crustaceans and echinoderms   All except [FL-no: 
09.608, 02.255 & 
07.262] 
10.0  Eggs and egg products  None 
11.0  Sweeteners, including honey  None 
12.0  Salts, spices, soups, sauces, salads, protein products etc.  All except [FL-no: 
07.156, 02.255 & 
07.262] 
13.0  Foodstuffs intended for particular nutritional uses  All  
14.1  Non-alcoholic ("soft") beverages, excl. dairy products  All  
14.2 Alcoholic  beverages, incl. alcohol-free and low-alcoholic counterparts  All except [FL-no: 
07.205] 
15.0  Ready-to-eat savouries  All except [FL-no: 
02.255, 07.157, 
09.609 & 07.262] 
16.0  Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not 
be placed in categories 1 – 15 
All exept [FL-no: 
02.255] 
According to the Flavour Industry the normal use levels for the 49 candidate substances are in the 
range of 1 - 30 mg/kg food, and the maximum use levels are in the range of 5 - 150 mg/kg (EFFA, 
2002b; EFFA, 2002f; EFFA, 2002i; EFFA, 2007a; EFFA, 2007b; EFFA, 2007k; Flavour Industry, 
2006p; Flavour Industry, 2009m). 
The mTAMDI values for the 28 candidate substances from structural class I (see Section 5) range 
from 1600 to 3900 µg/person/day. For the 21 candidate substance from structural class II the 
mTAMDI range from 1500 to 6600 µg/person/day. 
For detailed information on use levels and intake estimations based on the mTAMDI approach, see 
Section 6 and Annex II. 
4.  Absorption, Distribution, Metabolism and Elimination 
In general, aliphatic secondary alcohols and ketones are expected to be rapidly absorbed in the 
gastrointestinal tract. The candidate aliphatic esters are expected to be hydrolysed enzymatically to 
their component secondary alcohols and carboxylic acids. The carboxylic acids are completely 
oxidised in the fatty acid pathway and the tricarboxylic acid pathway (see Annex III).  Flavouring Group Evaluation 07, Revision 4
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Secondary alcohols may undergo oxidation to the corresponding ketone; however, in the in vivo 
situation the alcohol is removed from the equilibrium by conjugation to glucuronic acid, which 
represents the major pathway of metabolism for secondary alcohols. The glucuronides of the candidate 
secondary alcohols are expected to be eliminated via the urine (Felsted and Bachur, 1980; Kasper and 
Henton, 1980; JECFA, 1999a). 
In general, the major metabolic pathway for aliphatic ketones is reduction of the ketone to the 
corresponding secondary alcohol and subsequent excretion as glucuronic acid conjugate (Felsted and 
Bachur, 1980; JECFA, 1999a). 
Short chain ketones (C < 5) that contain a carbonyl function at the C2 position may undergo oxidation 
to yield an alpha-keto carboxylic acid, which through decarboxylation will be oxidised to carbon 
dioxide and a simple aliphatic carboxylic acid that will enter the fatty acid pathway and citric acid 
cycle (Dietz et al., 1981). Ketones may also be metabolised by omega- or omega-1-oxidation yielding 
a hydroxyketone that may be further reduced to a diol and excreted in the urine as glucuronic acid 
conjugate. Longer chain aliphatic ketones (C ≥ 5) are primarily metabolised via reduction, but omega- 
and omega-1-oxidation are competing pathways at high concentrations (Dietz et al., 1981; Topping et 
al., 1994).  
Omega-1-oxidation of certain aliphatic ketones may yield gamma-diketones, which may give rise to 
neuropathy of giant axonal type. The metabolic pathway includes oxidation of the omega-1-carbon, 
first to a hydroxyketone and then to a diketone. The gamma-spacing of the carbonyl functions has 
been shown to be a prerequisite for neurotoxic effects, thus, only ketones with this structural feature 
may yield the neurotoxic metabolites. Neurotoxic effects are however only observed at relatively high 
dosages (Topping et al., 1994). One of the candidate substances, 5-methylheptan-3-one [FL-no: 
07.182], may potentially be oxidised to a gamma-diketone.  
Eight of the candidate substances, 2,6-dimethylocta-1,5,7-triene-3-ol, Octa-1,5-dien-3-ol, Undeca-1,5-
dien-3-ol, hex-5-en-2-one, tridec-12-en-2-one, 3,3,6-trimethylhepta-1,5-dien-4-one, ([R-(E)]-5-
isopropyl-8-methylnona-6,8-dien-2-one and 9-decen-2-one [FL-no: 02.145, 02.194, 02.211, 07.162, 
07.201, 07.204, 07.239 and 07.262] have terminal double bonds. These double bonds may be oxidised 
to the corresponding epoxides. Epoxides are highly reactive molecules due to the large strain 
associated with the three membered ring structure, and they react easily with nucleophilic sites of 
cellular macromolecules. For this reason, several aliphatic alkene-derived epoxides (e.g. ethylene, 
isoprene, butadiene, and glycidol) have been demonstrated to be carcinogenic (Melnick, 2002). 
However, epoxides can be conjugated with glutathione by glutathione S-transferases or hydrolysed to 
diols by epoxide hydrolases. The latter two reactions can be considered to be detoxications. 1-Alkenes 
are metabolised by P450 through both double bond oxidation to the corresponding epoxide and allylic 
oxidation (Chiappe et al., 1998). The rates of the two reactions measured with different P450 isoforms 
indicate that epoxide formation is generally favoured (Chiappe et al., 1998). Therefore, due to the 
similar position of the double bond, it cannot be ruled out that these candidate substances may be, at 
least partially, biotransformed to an epoxide. However, based on the low levels of intake of alkenones 
and alkenols characterised by a carbonyl or an alcohol group in a distant position to the terminal 
double bond, it is expected that the detoxication reactions would not be saturated and would outweigh 
the rate of epoxide formation. The presence of the terminal double bond is therefore not considered of 
concern because epoxides can be detoxicated by conjugation with glutathione or by epoxide hydrolase 
mediated hydrolysis. 
Furthermore, based on genotoxicity data available, for seven out of 48 flavouring substances with 
terminal double bonds from the Register (EC, 1999a; EC, 2004a), it is not indicated that a terminal 
double bond distal to a functional group is a structural alert for genotoxicity. 
In addition to reduction and oxidation pathways, low molecular weight ketones may be excreted 
unchanged in expired air (Brown et al., 1987).  Flavouring Group Evaluation 07, Revision 4
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Concluding Remarks on Metabolism  
Among the candidate substances seven saturated aliphatic acyclic secondary alcohols, five unsaturated 
aliphatic secondary alcohols, 13 saturated aliphatic ketones, eight unsaturated aliphatic ketones and 16 
esters of aliphatic acyclic secondary alcohols and linear and branched chain aliphatic carboxylic acids 
may be expected to be metabolised to innocuous substances at the estimated level of intake, based on 
the MSDI approach, as flavouring substances.  
Eight of the candidate substances [FL-no: 02.145, 02.194, 02.211, 07.162, 07.201, 07.204, 07.239 and 
07.262] contain terminal double bonds. However, the presence of terminal double bonds in these eight 
substances is not considered of concern, because any oxidation of these double bonds to the 
corresponding epoxides can be detoxicated by conjugation with glutathione or by epoxide hydrolase 
mediated hydrolysis. 
One candidate substance, 5-methylheptan-3-one [FL-no: 07.182], may be oxidised to a potentially 
neurotoxic gamma-diketone.  
More detailed information on the metabolism of candidate substances is given in Annex III. 
5.  Application of the Procedure for the Safety Evaluation of Flavouring Substances 
The application of the Procedure is based on intakes estimated on the basis of the MSDI approach. 
Where the mTAMDI approach indicates that the intake of a flavouring substance might exceed its 
corresponding threshold of concern, a formal safety assessment is not carried out using the Procedure. 
In these cases the Panel requires more precise data on use and use levels. For comparison of the intake 
estimations based on the MSDI approach and the mTAMDI approach, see Section 6. 
For the safety evaluation of the 49 candidate substances the Procedure as outlined in Annex I was 
applied, based on the MSDI approach. The stepwise evaluations of the substances are summarised in 
Table 2a. 
Step 1 
Twenty-eight of the candidate substances [FL-no: 02.077, 02.124, 02.142, 02.148, 02.177, 02.182, 
02.183, 02.190, 02.255,  07.084, 07.178, 07.239, 09.304, 09.323, 09.325, 09.328, 09.332, 09.386, 
09.388, 09.391, 09.604, 09.605, 09.606, 09.608, 09.609, 09.676, 09.880 and 09.926] are classified in 
structural class I, according to the decision tree approach presented by Cramer et al. (Cramer et al., 
1978). The remaining 21 candidate substances [FL-no: 02.145, 02.194, 02.211, 07.072, 07.150, 
07.156, 07.157, 07.158, 07.160, 07.162, 07.181, 07.182, 07.185, 07.189, 07.198, 07.199, 07.201, 
07.204, 07.205, 07.236 and 07.262], which are unsaturated aliphatic secondary alcohols or acyclic 
aliphatic saturated or unsaturated ketones, are in structural class II. 
Step 2 
Forty-eight candidate substances were considered to be metabolised to innocuous products and would 
not be expected to saturate available detoxification pathways at estimated levels of intake, based on 
the MSDI approach, from use as flavouring substances. Therefore, these 48 substances proceed via the 
A-side of the Procedure scheme (Annex I).  
One candidate substance, 5-methylheptan-3-one [FL-no: 07.182], cannot be predicted to be 
metabolised to innocuous products and therefore, proceeds to step B3.  
Step A3 Flavouring Group Evaluation 07, Revision 4
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The 28 candidate substances assigned to structural class I, have estimated European daily per capita 
intakes ranging from 0.0012 to 1.3 µg (Table 2a). These intakes are below the threshold of concern of 
1800 µg/person/day for structural class I.  
The 20 unsaturated aliphatic secondary alcohols and ketones, which have been assigned to structural 
class II, have estimated European daily per capita intakes ranging from 0.0012 to 73 µg (Table 2a). 
These intakes are below the threshold of concern of 540 µg/person/day for structural class II. 
Based on results of the safety evaluation sequence, the 48 candidate substances proceeding via the A-
side of the Procedure do not pose a safety concern when used as flavouring substances at the estimated 
levels of intake, based on the MSDI approach. 
Step B3 
The estimated per capita intake of 5-methylheptan-3-one [FL-no: 07.182] of 0.32 µg/capita/day does 
not exceed the threshold of concern for structural class II of 540 µg/person/day. Accordingly, the 
candidate substance proceeds to step B4 of the Procedure. 
Step B4 
On the basis of a study on the neurotoxic effects of orally administered 5-methylheptan-3-one [FL-no: 
07.182] to male rats, a NOAEL of 82 mg/kg body weight (bw)/day was established (IBM Corp., 
1989). This NOAEL provides a margin of safety of 1.5 x 10
7 based on the estimated intake of the 
candidate substance of 0.32 µg/capita/day.  
Based on results of the safety evaluation sequence, this candidate substance does not pose a safety 
concern when used as flavouring substance at the estimated level of intake, based on the MSDI 
approach. 
6.  Comparison of the Intake Estimations Based on the MSDI Approach and the mTAMDI 
Approach 
The estimated intakes for the 28 candidate substances in structural class I based on the mTAMDI 
approach range from 1600 to 3900 µg/person/day. For three [FL-no: 07.084, 07.178 and 07.239] of 
these 28 substances, the mTAMDI is below the threshold of concern of 1800 µg/person/day. For 
comparison of the intake estimate based on the MSDI approach and mTAMDI approach, see Table 
6.1.  
The estimated intake for the 21 candidate substances assigned to structural class II based on the 
mTAMDI range from 1500 to 6600 µg/person/day, which are all above the threshold of concern for 
structural class II substances of 540 µg/person/day. For comparison of the MSDI- and mTAMDI-
values, see Table 6.1. 
For 46 candidate substances further information is required. This would include more reliable intake 
data and then, if required, additional toxicological data. 
For comparison of the MSDI and mTAMDI values, see Table 6.1. 
 
Table 6.1 Estimated intakes based on the MSDI approach and the mTAMDI approach 
FL-no  EU Register name  MSDI 
(μg/capita/day) 
mTAMDI 
(μg/person/day) 
Structural 
class 
Threshold of concern 
(µg/person/day) 
02.077 Pentan-3-ol  0.19  3900  Class  I  1800 
02.124 6-Methylhept-5-en-2-ol  0.0061  3900  Class  I  1800 
02.142 3,3-Dimethylbutan-2-ol  0.24  3900  Class  I  1800 
02.148 Dodecan-2-ol  0.35  3900  Class  I  1800 Flavouring Group Evaluation 07, Revision 4
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Table 6.1 Estimated intakes based on the MSDI approach and the mTAMDI approach 
FL-no  EU Register name  MSDI 
(μg/capita/day) 
mTAMDI 
(μg/person/day) 
Structural 
class 
Threshold of concern 
(µg/person/day) 
02.177 2-Methylhexan-3-ol  0.12  3900  Class  I  1800 
02.182 3-Methylpentan-2-ol  0.12  3900  Class  I  1800 
02.183 4-Methylpentan-2-ol  0.0012  3900  Class  I  1800 
02.190 Nonan-3-ol  0.011  3900  Class  I  1800 
02.255 (Z)-4-Hepten-2-ol  0.03  2500  Class  I  1800 
07.084 Pentan-3-one  0.24  1600  Class  I  1800 
07.178 3-Methylbutan-2-one  0.073  1600  Class  I  1800 
07.239 [R-(E)]-5-Isopropyl-8-methylnona-6,8-dien-2-
one 
0.24 1600  Class  I  1800 
09.304  sec-Heptyl isovalerate  0.0012  3900  Class I  1800 
09.323  sec-Butyl acetate  0.0012  3900  Class I  1800 
09.325  sec-Butyl butyrate  1.3  3900  Class I  1800 
09.328  sec-Butyl formate  0.12  3900  Class I  1800 
09.332  sec-Butyl hexanoate  0.024  3900  Class I  1800 
09.386  sec-Hept-4(cis)-enyl acetate  0.024  3900  Class I  1800 
09.388  sec-Heptyl acetate  0.12  3900  Class I  1800 
09.391  sec-Heptyl hexanoate  0.12  3900  Class I  1800 
09.604  Isopropyl decanoate  0.12  3900  Class I  1800 
09.605  Isopropyl dodecanoate  0.12  3900  Class I  1800 
09.606  Isopropyl hexadecanoate  0.012  3900  Class I  1800 
09.608  Isopropyl octanoate  1.3  3900  Class I  1800 
09.609  Isopropyl valerate  0.012  3500  Class I  1800 
09.676  sec-Octyl acetate  0.011  3900  Class I  1800 
09.880 Hept-4-enyl-2  butyrate  0.79  3900  Class  I  1800 
09.926  Octan-3-yl formate  0.24  3900  Class I  1800 
02.145 2,6-Dimethylocta-1,5,7-trien-3-ol  0.0085  3900  Class  II  540 
02.194 Octa-1,5-dien-3-ol  0.061  3900  Class  II  540 
02.211 Undeca-1,5-dien-3-ol  0.061  3900  Class  II  540 
07.072 6-Methylheptan-3-one  0.19  1600  Class  II  540 
07.150 Decan-2-one  0.52  1600  Class  II  540 
07.156 2,6-Dimethyloct-6-en-3-one  0.0012  1600  Class  II  540 
07.157 6,10-Dimethylundecan-2-one  0.085  1500  Class  II  540 
07.158 Dodecan-2-one  0.73  1600  Class  II  540 
07.160 Heptadecan-2-one  0.12  1600  Class  II  540 
07.162 Hex-5-en-2-one  0.049  1600  Class  II  540 
07.181 6-Methylheptan-2-one  0.0012  1600  Class  II  540 
07.185 3-Methylpentan-2-one  1.2  1600  Class  II  540 
07.189 Nonan-4-one  0.52  1600  Class  II  540 
07.198 Pseudo-ionone  0.12  1600  Class  II  540 
07.199 Tetradecan-2-one  0.073  1600  Class  II  540 
07.201 Tridec-12-en-2-one  0.024  1600  Class  II  540 
07.204 3,3,6-Trimethylhepta-1,5-dien-4-one  0.012  1600  Class  II  540 
07.205 6,10,14-Trimethylpentadecan-2-one  0.0073  1500  Class  II  540 
07.236 5-Octen-2-one  0.0097  1600  Class  II  540 
07.262 9-Decen-2-one  73  6600  Class  II  540 
07.182 5-Methylheptan-3-one  0.32  1600  Class  II  540 
7.  Considerations of Combined Intakes from Use as Flavouring Substances 
Because of structural similarities of candidate and supporting substances, it can be anticipated that 
many of the flavourings are metabolised through the same metabolic pathways and that the 
metabolites may affect the same target organs. Further, in case of combined exposure to structurally 
related flavourings, the pathways could be overloaded. Therefore, combined intake should be 
considered. As flavourings not included in this FGE may also be metabolised through the same 
pathways, the combined intake estimates presented here are only preliminary. Currently, the combined 
intake estimates are only based on MSDI exposure estimates, although it is recognised that this may 
lead to underestimation of exposure. After completion of all FGEs, this issue should be readdressed. 
The total estimated combined daily per capita intake of structurally related flavourings is estimated by 
summing the MSDI for individual substances. 
On the basis of the reported annual production volumes in Europe (EFFA, 2002e; EFFA, 2002f; 
EFFA, 2007k; Flavour Industry, 2009m), the total estimated daily per capita intake as flavourings of 
the 28 candidate flavouring substances assigned to structural class I is 6 µg, which does not exceed the Flavouring Group Evaluation 07, Revision 4
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threshold of concern for a substance belonging to structural class I of 1800 µg/person/day. For the 
combined intake of the 21 candidate flavouring substances assigned to structural class II is 77 µg, 
which does not exceed the threshold of concern for a substance belonging to structural class II of 540 
µg/person/day.  
The 49 candidate substances are structurally related to 58 supporting substances evaluated by the 
JEFCA at its 51
st meeting (JECFA, 1999a), 59
th meeting (JECFA, 2003a) and 69
th meeting (JECFA, 
2009c). The total combined intake of candidate and supporting substances of structural class I and II 
would be 90400 µg/capita/day and 1200 µg/capita/day, respectively. Both intakes exceed the threshold 
of their structural class of 1800 and 540 µg/person/day. However, the major contribution (> 99 %) was 
provided by two supporting substances, namely acetone [FL-no: 07.050] (6100 µg/capita/day) and 
isopropanol [FL-no: 02.079] (84000 µg/capita/day). These are present in the body as endogenous 
compounds, which are easily eliminated from the body either by excretion into the urine and exhaled 
air or after enzymatic metabolism (Morgott, 1993). Therefore, they would not be expected to give rise 
to perturbations outside the physiological range (JECFA, 1999a). Excluding the two major 
contributors, the estimated total combined intake (in Europe) for the candidate and supporting 
substances belonging to structural class I would be 340 µg/capita/day, which does not exceed the 
threshold of concern for the corresponding structural class (1800 µg person/day); whereas the 
estimated total combined intake (in Europe) for the candidate and supporting substances belonging to 
structural class II would be 1200 µg/capita/day, which is approximately two fold higher than the 
threshold of concern for the corresponding structural class (540 µg/person/day). However, these levels 
may be expected not to saturate the detoxification reactions involved in biotransformation of these 
compounds to innocuous products. 
In the case that the candidate substance 5-methylheptan-3-one [FL-no: 07.182] and the two supporting 
substances heptan-3-ol [FL-no: 02.044] and 3-heptanone [FL-no: 07.003], which can all be 
metabolised to neurotoxic gamma-diketones, were consumed concomitantly on a daily basis, the 
estimated combined intake (in Europe) would be 3.7 µg/capita/day, corresponding to 0.06 µg/kg 
bw/day. This value does not exceed the threshold of concern for the corresponding structural class II 
(540 µg/person/day) and is also much lower than the NOAEL for 5-methylheptan-3-one [FL-no: 
07.182] of 82 mg/kg bw/day for neurotoxicity in the rat. Therefore, it can be concluded that there is no 
safety concern for human health for the combined exposure to these three neurotoxic substances at the 
estimated level of intake as flavourings. 
8.  Toxicity 
8.1.  Acute Toxicity 
Data are available for 12 candidate substances under consideration and for 23 supporting substances. 
Most of the candidate and supporting substances have rat and/or mouse oral LD50 values exceeding 
2000 mg/kg body weight (bw) indicating that their oral acute toxicity is low.  
The acute toxicity data are summarised in Annex IV, Table IV.1. 
8.2.  Subacute, Subchronic, Chronic and Carcinogenicity Studies 
Data on oral subchronic toxicity are available for three candidate substances, pentan-3-one [FL-no: 
07.084], 5-methylheptan-3-one [FL-no: 07.182] and 9-decen-2-one [FL-no: 07.262] with identification 
of a No Observed Adverse Effect Level (NOAEL). Data on subacute and subchronic oral toxicity are 
also available for ten supporting substances, one saturated aliphatic secondary alcohol [FL-no: 
02.079], seven saturated [FL-no: 07.002, 07.003, 07.017, 07.020, 07.050, 07.058, 07.122] and two 
unsaturated [FL-no: 07.100 and 07.114] aliphatic ketones evaluated by JEFCA (JECFA, 1999a; 
JECFA, 2003a).  Flavouring Group Evaluation 07, Revision 4
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During the application of the Procedure (Annex I), the following study on 5-methylheptan-3-one [FL-
no: 07.182], which possesses structural alerts for neurotoxicity, has been used to calculate the 
NOAEL: 
5-Methylheptan-3-one [FL-no: 07.182] (purity 98.9 %) dissolved in distilled water was administered 
by gavage to groups of five adult male Sprague Dawley rats at dose levels 0, 82, 410 and 820 mg/kg 
bw/day, five days/week for 13 weeks.  
In the high-dose group clinical signs, including depression of activity, gait disturbances, reductions in 
food consumption and body weight gain were observed; moreover, results of the Functional 
Observational Battery (FOB) indicated peripheral neuropathy. Similar clinical signs and functional 
deficits were observed less frequently and with reduced severity in the mid-dose group. No functional 
deficits were observed in the low-dose group animals. Microscopic histopathological examinations of 
the sciatic and tibial nerves from high-dose animals revealed lesions typical of the “giant” axonal 
neuropathy produced by gamma-diketones. Changes observed in the mid-dose group animals reflected 
the occurrence of reparative processes in the nerves. Nerves from the low-dose group animals did not 
show any evidence of pathology attributable to treatment. Based on behavioural effects and 
microscopic changes occurring at 410 and 820 mg/kg bw/day, the NOAEL for 5- methylheptan-3-one-
induced neurotoxicity was 82 mg/kg bw/day (IBM Corp., 1989). 
The repeated-dose toxicity data are summarised in Annex IV, Table IV.2. 
8.3.  Developmental / Reproductive Toxicity Studies 
Data on reproductive toxicity are available for pentan-3-one [FL-no: 07.084] and data on 
developmental toxicity are available for pseudo-ionone [FL-no: 07.198]. For one supporting 
substance, isopropyl alcohol [FL-no: 02.079], data are available on both developmental and 
reproductive toxicity. With a NOAEL of 50 mg/kg bw/day for intraperitoneal administration in mice 
for [FL-no: 07.084] and of 960 mg/kg bw/day for oral administration of [FL-no: 07.198] it was 
concluded that the developmental / reproductive toxicity was low after oral exposure. 
The developmental/reproductive toxicity data are summarised in Annex IV, Table IV.3. 
8.4.  Genotoxicity Studies 
In vitro genotoxicity data have been reported for nine candidate substances. Negative results were 
obtained in bacterial systems (+/- metabolic activation) with six candidate substances, one saturated 
aliphatic acyclic secondary alcohol [FL-no: 02.183], two saturated ketones [FL-no: 07.181 and 
07.205], two unsaturated ketones [FL-no: 07.198 and 07.262] and the ester isopropyl hexadecanoate 
[FL-no: 09.606]. Negative results were also obtained for the candidate substances pseudo-ionone [FL-
no: 07.198], pentan-3-ol [FL-no: 02.077] and methyl-3-butan-2-one [FL-no: 07.178], the two first 
mentioned being tested for chromosomal aberrations in mammalian cells and the latter for induction of 
aneuploidy in yeast cells, respectively.  
Induction of aneuploidy in yeast cells has been demonstrated for pentan-3-one [FL-no: 07.084]. The 
effect, measured only at high concentrations, approaching cytotoxic levels, can be considered to be a 
threshold effect, not mediated by direct interaction with DNA. In addition, induction of aneuploidy 
described in the paper is strongly potentiated by ice treatments included in the experimental protocol, 
consistently with tubulin dissociation at low temperature in vitro; in the absence of this passage the 
effect is very weak. Therefore, the effect could be considered as an effect occurring only under 
unrealistic experimental conditions and the extrapolation of this result to the in vivo situation in 
humans is questionable. Furthermore, it is well recognised that the relevance of fungal systems is 
limited when induction of aneuploidy in mammalian systems has to be evaluated. 
Pseudo-ionone [FL-no: 07.198] was considered with respect to genotoxicity in FGE.206 (EFSA, 
2011c) where the Panel concluded that the data available ruled out the concern for genotoxicity. Flavouring Group Evaluation 07, Revision 4
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Pseudo-ionone was tested in Salmonella typhimurium strains TA98, TA100, TA1535, TA1537 and 
TA102 in the presence or absence of S9 and it is concluded that under the test conditions applied 
pseudo-ionone is not mutagenic in bacteria. Pseudo-ionone was also evaluated in an in vitro 
micronucleus assay in human peripheral blood lymphocytes for its ability to induce chromosomal 
damage or aneuploidy in the presence and absence of rat S9 fraction as an in vitro metabolising 
system. Under the conditions of this study, pseudo-ionone was not clastogenic and/or aneugenic in 
cultured human lymphocytes. 
In vitro genotoxicity data are also available for 10 supporting substances.  
No evidence of mutagenicity obtained with either bacterial or mammalian cells systems was reported 
for one saturated aliphatic acyclic secondary alcohol [FL-no: 02.079], five saturated [FL-no: 07.002, 
07.050, 07.017, 07.053 and 07.122], two unsaturated [FL-no: 07.015 and 07.099] aliphatic acyclic 
ketones and two esters of an aliphatic acyclic secondary alcohol with linear aliphatic carboxylic acids 
[FL-no: 09.003 and 09.105]. 4-Methyl-2-pentanone [FL-no: 07.017] gave negative results also when 
tested for chromosomal aberration activity. 
Beside the negative results in in vitro bacterial point mutation tests, acetone [FL-no: 07.050] showed 
no evidence of increased sister chromatid exchanges in several cytogenetic assays on different 
mammalian cells, as well as no induction of chromosomal aberrations in Chinese hamster ovary cells 
up to very high concentrations. Only one test on hamster lung fibroblasts (conducted at an unspecified 
acetone concentration) and an aneuploidy induction test on Saccharomyces cerevisiae (about 7 % 
acetone) gave positive results. However, these two studies were considered not relevant on the basis of 
their poor quality and taking into account all the other negative genotoxicity results obtained with 
acetone, including results in vivo (see below).  
6-Methylhepta-3,5-dien-2-one [FL-no: 07.099] was considered with respect to genotoxicity in 
FGE.206 (EFSA, 2011c) where the Panel concluded that the data available ruled out the concern for 
genotoxicity. 6-Methylhepta-3,5-dien-2-one was tested in Salmonella typhimurium strains TA98, 
TA100, TA1535, TA1537 and TA102 in the presence or absence of S9 and it was concluded that 
under the test conditions applied 6-methylhepta-3,5-dien-2-one is not mutagenic in bacteria. 6-
Methylhepta-3,5-dien-2-one was also evaluated in an in vitro micronucleus assay in human peripheral 
blood lymphocytes for its ability to induce chromosomal damage or aneuploidy in the presence and 
absence of rat S9 fraction as an in vitro metabolising system. Under the conditions of this study, 6-
methylhepta-3,5-dien-2-one was not clastogenic and/aneugenic in cultured human lymphocytes. 
In vivo data are available for four supporting substances: one saturated aliphatic secondary alcohol 
[FL-no: 02.079] and three saturated aliphatic ketones [FL-no: 07.017, 07.050 and 07.053], which 
exhibited no genotoxic potential in the micronucleus cytogenetic assay at doses approaching the LD20 
and the LD50 of the tested substances.  
On the basis of available data from in vitro and in vivo tests on candidate and supporting substances, it 
can be concluded that the 49 candidate substances included in this group exhibit no genotoxic 
potential. 
The genotoxicity data are summarised in Annex IV, Table IV.4 and 5. 
8.5.  Other Information 
Pseudo-ionone [FL-no: 07.198] has been subjected to investigations concerning its potential as a 
dermal sensitizer as follows: 
a)  A guinea pig study (Csato and Chubb, 1996) performed as a GLP OECD 406 maximization 
test. There were some problems with reading the result after challenge because of intense red-
brown skin staining. Therefore a re-challenge was performed seven days later, when skin 
staining was much reduced and did not prevent assessment of the skin reaction. Test agent Flavouring Group Evaluation 07, Revision 4
 
EFSA Journal 2012;10(10):2899  20
concentrations were 3.125 % and 1.563 % in water, scoring was performed after 24 and 48 
hours. None of the animals in the control (n=10) or test (n=20) groups showed a reaction. 
Based on this guinea pig maximization test performed under GLP conditions according to 
OECD guidelines, pseudo-ionone is not a dermal sensitizer. However, the problems with skin 
staining and delayed challenge possibly may bring in some uncertainty (contribution toward 
false negative results). 
b)  Four maximization test series with pseudo-ionone were carried out on a total of 108 human 
volunteers by Kligman (Kligman, 1976) [unpublished] and Epstein (Epstein, 1978) 
[unpublished]. Test concentration was 8 % in petrolatum. The outcome was “2/25 (Kligman, 
1976), 4/25 (Epstein, 1978), 2/25 (Kligman, 1976), and 1/33 (Epstein, 1978) sensitization 
reactions”, as reported by Ford et al. (Ford et al. 1988c). Thus, there were altogether 9 positive 
out of 108 subjects (8.3 %). No further details are given by Ford and the original reports never 
were published. The fact that pseudo-ionone is an irritant still may bring in some uncertainty 
(contribution towards false positive results). 
Based on the human studies there is evidence that pseudo-ionone may be a weak dermal sensitizer. In 
accordance with this and as based on the report by Ford et al. (Ford et al. 1988c), both the 
International Fragrance Association (IFRA, 2002) and subsequently the European Union Scientific 
Committee on Cosmetic Products and Non-Food Products (EFFA, 2012t) recommended a ban on the 
use of pseudo-ionone as a fragrance ingredient but tolerated it as an impurity at ≤ 2 % in various 
ionones.  
Considering that allergic contact sensitization in the mouth to components in ingested food is 
extremely rare (EFSA, 2012o), that worsening of skin manifestations of contact dermatitis after 
ingestion of foods with relatively high levels of the allergen appears to be an uncommon occurrence, 
and that contact allergic manifestations in the gut although claimed in rare cases have not been well 
described, it is unlikely that pseudo-ionone used as a flavouring substance will cause allergic 
reactions. 
9.  Conclusions 
The 49 candidate substances are saturated and unsaturated aliphatic secondary alcohols, ketones and 
esters of secondary alcohols and saturated linear or branched-chain saturated carboxylic acids from 
chemical group 5. 
Twenty-five candidate substances possess one chiral centre [FL-no: 02.124, 02.142, 02.145, 02.148, 
02.177, 02.183, 02.190, 02.194, 02.211, 02.255, 07.157, 07.182, 07.185, 07.239, 09.304, 09.323, 
09.325, 09.328, 09.332, 09.386, 09.388, 09.391, 09.676, 09.880 and 09.926], and two of the candidate 
substances possess two chiral centres [FL-no: 02.182 and 07.205]. The stereoisomeric compositions 
have not been specified sufficiently for three substances [FL-no: 02.194, 02.211 and 02.255]. 
Due to the presence and the position of double bonds, 10 candidate substances can exist as geometrical 
isomers [FL-no: 02.145, 02.194, 02.211, 02.255, 07.156, 07.198, 07.236, 07.239, 09.386, and 09.880]. 
For one of these [FL-no: 07.156], the stereoisomeric composition has been specified as the E/Z 
mixture, but the composition of the mixture has not been given. 
Twenty-eight candidate substances belong to structural class I, and 21 candidate substances belong to 
structural class II.  
Forty-five of the flavouring substances in the present group of 49 flavouring substances have been 
reported to occur naturally in a wide range of food items. 
According to the default MSDI approach, the 49 candidate substances have European daily per capita 
intakes ranging from 0.0012 to 73 µg, which are below the threshold of concern for structural class I 
and class II substances (1800 and 540 µ/person/day, respectively).  Flavouring Group Evaluation 07, Revision 4
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On the basis of the reported annual production in Europe (MSDI approach), the combined intakes of 
the 28 of the candidate substances belonging to structural class I and of the 21 candidate substances 
belonging to structural class II would result in total intakes of 6 and 77 µg/capita/day, respectively. 
These values are lower than the thresholds of concern for structural class I or class II substances. The 
total combined estimated levels of intake of the candidate and supporting substances is approximately 
340 µg/capita/day (without acetone and isopropanol) for structural class I substances and 1200 
µg/capita/day for structural class II substances. This latter value does exceed the threshold of concern 
for the structural class. However, this level is not expected to saturate the detoxication reactions able 
to biotransform these compounds to innocuous products. 
On the basis of available data from in vitro and in vivo tests on candidate and supporting substances, it 
can be concluded that the 49 candidate substances included in this group exhibit no genotoxic 
potential. 
Forty-eight candidate substances would be expected to be metabolised to innocuous substances at the 
estimated levels of intake as flavouring substances. 
One candidate substance, 5-methylheptan-3-one [FL-no: 07.182], may be oxidised to a potential 
neurotoxic gamma-diketone. However, this metabolic path does not pose a safety concern at the 
estimated level of intake as a flavouring substance. Indeed, for this substance a NOAEL for 
neurotoxicity of 82 mg/kg bw/day was established in a subchronic study on adult male rats dosed with 
0, 82, 410 and 820 mg/kg bw/day for 13 weeks. This NOAEL provides a margin of safety of 1.5 x 10
7 
based on the estimated intake of the candidate substance of 0.32 µg/capita/day.   
Otherwise it was noted, that where toxicity data were available on single flavouring substances, they 
were consistent with the conclusions in the present FGE using the Procedure.  
It is considered that on the basis of the default MSDI approach, none of the 49 candidate substances 
would give rise to safety concerns at the estimated levels of intake arising from their use as flavouring 
substances. 
When the estimated intakes were based on the mTAMDI they ranged from 1600 to 3900 
µg/person/day for the 28 candidate substances from structural class I. The intakes were all above the 
threshold of concern for structural class I of 1800 µg/person/day, except for three flavouring 
substances [FL-no: 07.084, 07.178 and 07.239]. The estimated intakes of the 21 candidate substances 
assigned to structural class II, based on the mTAMDI, range from 1500 to 6600 µg/person/day, which 
are all above the threshold of concern for structural class II of 540 µg/person/day. The three 
substances [FL-no: 07.084, 07.178 and 07.239], which have mTAMDI intake estimates below the 
threshold of concern for the structural class, are also expected to be metabolised to innocuous 
products. 
Thus, for 46 of the 49 candidate substances considered in this Opinion the intakes, estimated on the 
basis of the mTAMDI, exceed the relevant threshold for their structural class, to which the flavouring 
substance has been assigned. Therefore, for these 46 substances more reliable exposure data are 
required. On the basis of such additional data, these flavouring substances should be reconsidered 
along the steps of the Procedure. Following this procedure additional toxicological data might become 
necessary.  
In order to determine whether the conclusion for the 49 candidate substances evaluated through the 
Procedure can be applied to the materials of commerce, it is necessary to consider the available 
specifications. Adequate specifications including purity and identity for the materials of commerce 
have been provided for all the candidate substances. The stereoisomeric compositions have not been 
specified for three substances [FL-no: 02.194, 02.211 and 02.255]. For one substance [FL-no: 07.156], 
the stereoisomeric composition has been specified as the E/Z mixture, but the composition of the Flavouring Group Evaluation 07, Revision 4
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mixture has not been given. Thus, the final evaluation of the materials of commerce cannot be 
performed for these substances, pending further information. 
The remaining 45 substances [FL-no: 02.077, 02.124, 02.142, 02.145, 02.148, 02.177, 02.182, 02.183, 
02.190, 07.072, 07.084, 07.150, 07.157, 07.158, 07.160, 07.162, 07.178, 07.181, 07.182, 07.185, 
07.189, 07.198, 07.199, 07.201, 07.204, 07.205, 07.236, 07.239, 07.262, 09.304, 09.323, 09.325, 
09.328, 09.332, 09.386, 09.388, 09.391, 09.604, 09.605, 09.606, 09.608, 09.609, 09.676, 09.880 and 
09.926] would present no safety concern at the levels of intake estimated on the basis of the MSDI 
approach. Flavouring Group Evaluation 07, Revision 4
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TABLE 1: SPECIFICATION SUMMARY OF THE SUBSTANCES IN THE FLAVOURING GROUP EVALUATION 7, REVISION 4 
Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 7, Revision 4 
FL-no  EU Register name  Structural formula  FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
Specification comments 
02.077 
 
Pentan-3-ol 
 
 
2349 
584-02-1 
Liquid 
C5H12O 
88.15 
Slightly soluble 
Freely soluble 
115 
 
MS 
98 % 
1.407-1.413 
0.815-0.822 
 
 
02.124 
 
6-Methylhept-5-en-2-ol 
 
 
10264 
1569-60-4 
Liquid 
C8H16O 
128.21 
Slightly soluble 
Freely soluble 
77 (20 hPa) 
 
MS 
95 % 
1.447-1.453 
0.848-0.854 
 
Racemate. 
02.142 
 
3,3-Dimethylbutan-2-ol 
 
 
 
464-07-3 
Liquid 
C6H14O 
102.18 
Slightly soluble 
Freely soluble 
120 
 
MS 
95 % 
1.410-1.416 
0.814-0.820 
 
Racemate. 
02.145 
 
2,6-Dimethylocta-1,5,7-trien-3-ol  
 
29414-56-0 
Liquid 
C10H16O 
152.24 
Slightly soluble 
Freely soluble 
240 
 
MS 
95 % 
1.484-1.490 
0.895-0.901 
 
Racemate. Mixture of E/Z 
stereoisomers: 50-80 % (E) 
(EFFA, 2012c). 
02.148 
 
Dodecan-2-ol 
 
 
11760 
10203-28-8 
Liquid 
C12H26O 
186.34 
Insoluble 
Freely soluble 
129 (15 hPa) 
19 
MS 
95 % 
1.438-1.444 
0.829-0.835 
 
Racemate. 
02.177 
 
2-Methylhexan-3-ol   
10266 
617-29-8 
Liquid 
C7H16O 
116.20 
Slightly soluble 
Freely soluble 
144 
 
MS 
95 % 
1.418-1.424 
0.820-0.826 
 
Racemate. 
02.182 
 
3-Methylpentan-2-ol   
10276 
565-60-6 
Liquid 
C6H14O 
102.18 
Insoluble 
Freely soluble 
134 
 
MS 
95 % 
1.415-1.421 
0.827-0.833 
 
Racemate (EFFA, 2010a). 
02.183 
 
4-Methylpentan-2-ol 
 
 
10279 
108-11-2 
Liquid 
C6H14O 
102.18 
Slightly soluble 
Freely soluble 
132 
 
MS 
99 % 
1.407-1.414 
0.802-0.808 
 
Racemate. 
02.190 
 
Nonan-3-ol 
 
 
10290 
624-51-1 
Liquid 
C9H20O 
144.26 
Practically insoluble 
or insoluble 
Freely soluble 
195 
 
MS 
95 % 
1.425-1.431 
0.818-0.824 
 
Racemate (EFFA, 2010a). 
02.194 
 
Octa-1,5-dien-3-ol   6) 
 
 
 
83861-74-9 
Liquid 
C8H14O 
126.20 
Practically insoluble 
or insoluble 
Freely soluble 
187 
 
MS 
95 % 
1.441-1.447 
0.832-0.838 
 
Mixture of E/Z 
stereoisomers: 60-90 % (E) 
(EFFA, 2012c). 
Stereoisomeric composition 
of optical isomers not 
OH
OH
OH
OH
OH
OH
OH
OH
OH
OHFlavouring Group Evaluation 07, Revision 4
 
EFSA Journal 2012;10(10):2899  24
Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 7, Revision 4 
FL-no  EU Register name  Structural formula  FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
Specification comments 
specified.  
02.211 
 
Undeca-1,5-dien-3-ol   6) 
 
 
 
56722-23-7 
Liquid 
C11H20O 
168.28 
Practically insoluble 
or insoluble 
Freely soluble 
244 
 
NMR 
95 % 
1.456-1.462 
0.872-0.878 
 
Mixture of E/Z 
stereoisomers: 60-90 % (E) 
(EFFA, 2012c). 
Stereoisomeric composition 
of optical isomers not 
specified. 
02.255 
 
(Z)-4-Hepten-2-ol   6) 
 
 
 
66642-85-1 
Liquid 
C7H14O 
114.19 
Insoluble 
Freely soluble 
154 
 
MS 
91.77 % 
1.433-1.453 
0.832-0.852 
 
Mixture of (Z)-isomer 
(approx. 92 %), (E)-isomer 
(approx. 4 %). Minor 
constituents 2-heptanol (<1 
), trans-3-hepten-2-ol (<1 
%), cis 3-hepten-2-ol (<1 %) 
(EFFA, 2010a). 
Stereoisomeric composition 
of optical isomers not 
specified. 
07.072 
 
6-Methylheptan-3-one   
2143 
624-42-0 
Liquid 
C8H16O 
128.21 
Insoluble 
Freely soluble 
162 
 
MS 
95 % 
1.412-1.418 
0.813-0.819 
 
 
07.084 
 
Pentan-3-one 
 
 
2350 
96-22-0 
Liquid 
C5H10O 
86.13 
Partly soluble 
Freely soluble 
102 
 
MS 
99 % 
1.389-1.395 
0.812-0.818 
 
 
07.150 
 
Decan-2-one 
 
 
11055 
693-54-9 
Liquid 
C10H20O 
156.27 
Insoluble 
Freely soluble 
210 
 
MS 
98 % 
1.423-1.429 
0.821-0.827 
 
 
07.156 
 
2,6-Dimethyloct-6-en-3-one 
 
 
 
2550-18-7 
Liquid 
C10H18O 
154.25 
Insoluble 
Freely soluble 
80 (13 hPa) 
 
NMR 
95 % 
1.442-1.448 
0.823-0.829 
 
Mixture of (Z)- and (E)-
isomers (EFFA, 2010a). 
Composition of 
stereoisomeric mixture to be 
specified. 
The CASrn to be changed to 
90975-15-8 (EFFA, 2010a). 
07.157 
 
6,10-Dimethylundecan-2-one 
 
 
11068 
1604-34-8 
Liquid 
C13H26O 
198.35 
Insoluble 
Freely soluble 
121 (16 hPa) 
 
MS 
95 % 
1.433-1.439 
0.828-0.834 
 
Racemate. 
07.158 
 
Dodecan-2-one   
11069 
Liquid 
C12H24O 
Insoluble 
Freely soluble 
119 (13 hPa) 
20 
1.431-1.437 
0.825-0.835 
 
 
OH
OH
O
O
O
O
(E)- isomer shown
O
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 7, Revision 4 
FL-no  EU Register name  Structural formula  FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
Specification comments 
6175-49-1 184.32  MS 
99 % 
07.160 
 
Heptadecan-2-one 
 
 
11089 
2922-51-2 
Solid 
C17H34O 
254.46 
Insoluble 
Freely soluble 
144 (1 hPa) 
48 
MS 
95 % 
n.a. 
n.a. 
 
 
07.162 
 
Hex-5-en-2-one 
 
 
 
109-49-9 
Liquid 
C6H10O 
98.14 
Slightly soluble 
Freely soluble 
128 
 
MS 
95 % 
1.418-1.424 
0.839-0.845 
 
 
07.178 
 
3-Methylbutan-2-one 
 
 
11131 
563-80-4 
Liquid 
C5H10O 
86.13 
Slightly soluble 
Freely soluble 
94 
 
MS 
95 % 
1.387-1.393 
0.801-0.807 
 
 
07.181 
 
6-Methylheptan-2-one 
 
 
11146 
928-68-7 
Liquid 
C8H16O 
128.21 
Insoluble 
Freely soluble 
167 
 
MS 
95 % 
1.412-1.418 
0.813-0.819 
 
 
07.182 
 
5-Methylheptan-3-one 
 
 
 
541-85-5 
Liquid 
C8H16O 
128.21 
Insoluble 
Freely soluble 
158 
 
MS 
95 % 
1.418-1.424 
0.816-0.824 
 
Racemate. 
07.185 
 
3-Methylpentan-2-one   
11157 
565-61-7 
Liquid 
C6H12O 
100.16 
Insoluble 
Freely soluble 
117 
 
MS 
95 % 
1.398-1.404 
0.810-0.816 
 
Racemate. 
07.189 
 
Nonan-4-one 
 
 
11161 
4485-09-0 
Liquid 
C9H18O 
142.24 
Insoluble 
Freely soluble 
188 
 
MS 
95 % 
1.416-1.422 
0.821-0.827 
 
 
07.198 
 
Pseudo-ionone 
 
4299 
11191 
141-10-6 
Liquid 
C13H20O 
192.30 
Insoluble 
Freely soluble 
144 (16 hPa) 
 
MS 
95 % 
1.529-1.535 
0.894-0.903 
 
Mixture of E/Z 
stereoisomers: >50 % (EE) 
(EFFA, 2012c).  
07.199 
 
Tetradecan-2-one 
 
 
11192 
2345-27-9 
Solid 
C14H28O 
212.37 
Insoluble 
Freely soluble 
146 (16 hPa) 
33 
MS 
95 % 
n.a. 
n.a. 
 
 
07.201 
 
Tridec-12-en-2-one 
 
 
 
60437-21-0 
Liquid 
C13H24O 
196.33 
Insoluble 
Freely soluble 
129 (13 hPa) 
 
NMR 
95 % 
1.441-1.447 
0.815-0.821 
 
 
O
O
O
O
O
O
O
O
O
OFlavouring Group Evaluation 07, Revision 4
 
EFSA Journal 2012;10(10):2899  26
Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 7, Revision 4 
FL-no  EU Register name  Structural formula  FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
Specification comments 
07.204 
 
3,3,6-Trimethylhepta-1,5-dien-4-
one 
 
 
546-49-6 
Liquid 
C10H16O 
152.24 
Practically insoluble 
or insoluble 
Freely soluble 
181 
 
MS 
95 % 
1.462-1.468 
0.867-0.873 
 
 
07.205 
 
6,10,14-Trimethylpentadecan-2-
one 
 
 
11205 
502-69-2 
Liquid 
C18H36O 
268.48 
Insoluble 
Freely soluble 
174 (13 hPa) 
 
MS 
95 % 
1.445-1.451 
0.834-0.840 
 
Racemate. 
07.236 
 
5-Octen-2-one   
11171 
22610-86-2 
Liquid 
C8H14O 
126.20 
Practically insoluble 
or insoluble 
Freely soluble 
115 
 
NMR 
95 % 
1.431-1.437 
0.842-0.848 
 
Register name to be changed 
to (Z)-5-octen-2-one (EFFA, 
2010a). 
07.239 [R-(E)]-5-Isopropyl-8-
methylnona-6,8-dien-2-one 
4331 
 
2278-53-7 
Liquid 
C13H22O 
194.31 
Practically insoluble 
or insoluble 
Freely soluble 
238 
 
MS 
95 % 
1.471-1.477 
0.846-0.852 
 
 
07.262 
 
9-Decen-2-one 
 
4706 
 
35194-30-0 
Liquid 
C10H18O 
154 
Slightly soluble 
Soluble 
206.3 
 
IR NMR MS 
99 % 
1.426-1.446 
0.834-0.854 
 
 
09.304 
 
sec-Heptyl isovalerate 
 
 
10806 
238757-71-6 
Liquid 
C12H24O2 
200.32 
Insoluble 
Freely soluble 
235 
 
NMR 
95 % 
1.423-1.429 
0.867-0.873 
 
Racemate. 
09.323 
 
sec-Butyl acetate 
 
 
10527 
105-46-4 
Liquid 
C6H12O2 
116.16 
Slightly soluble 
Freely soluble 
111 
 
MS 
95 % 
1.385-1.391 
0.867-0.873 
 
Racemate. 
09.325 
 
sec-Butyl butyrate 
 
 
10528 
819-97-6 
Liquid 
C8H16O2 
144.21 
Slightly soluble 
Freely soluble 
152 
 
MS 
95 % 
1.399-1.405 
0.858-0.864 
 
Racemate. 
09.328 
 
sec-Butyl formate 
 
 
10532 
589-40-2 
Liquid 
C5H10O2 
102.13 
Slightly soluble 
Freely soluble 
94 
 
MS 
95 % 
1.386-1.392 
0.877-0.883 
 
Racemate. 
09.332 
 
sec-Butyl hexanoate 
 
 
10533 
820-00-8 
Liquid 
C10H20O2 
172.27 
Insoluble 
Freely soluble 
82 (21 hPa) 
 
NMR 
95 % 
1.408-1.414 
0.861-0.867 
 
Racemate. 
09.386 
 
sec-Hept-4(cis)-enyl acetate 
 
 
 
94088-33-2 
Liquid 
C9H16O2 
156.22 
Insoluble 
Freely soluble 
185 
 
MS 
95 % 
1.412-1.418 
0.854-0.860 
 
Racemate. 
O
O
O
(Z)-isomer shown
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 7, Revision 4 
FL-no  EU Register name  Structural formula  FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
Specification comments 
09.388 
 
sec-Heptyl acetate 
 
 
10802 
5921-82-4 
Liquid 
C9H18O2 
158.24 
Insoluble 
Freely soluble 
172 
 
MS 
95 % 
1.406-1.412 
0.862-0.868 
 
Racemate. 
09.391 
 
sec-Heptyl hexanoate 
 
 
10805 
6624-58-4 
Liquid 
C13H26O2 
214.35 
Insoluble 
Freely soluble 
126 (20 hPa) 
 
MS 
95 % 
1.421-1.427 
0.851-0.857 
 
Racemate. 
09.604 
 
Isopropyl decanoate 
 
 
10730 
2311-59-3 
Liquid 
C13H26O2 
214.35 
Insoluble 
Freely soluble 
88 (3 hPa) 
 
MS 
95 % 
1.421-1.427 
0.851-0.857 
 
 
09.605 
 
Isopropyl dodecanoate 
 
 
 
10233-13-3 
Liquid 
C15H30O2 
242.40 
Insoluble 
Freely soluble 
105 (1 hPa) 
 
MS 
95 % 
1.427-1.433 
0.851-0.857 
 
 
09.606 
 
Isopropyl hexadecanoate   
10732 
142-91-6 
Liquid 
C19H38O2 
298.51 
Insoluble 
Freely soluble 
342 
13 
MS 
95 % 
1.433-1.439 
0.852-0.858 
 
 
09.608 
 
Isopropyl octanoate 
 
 
10731 
5458-59-3 
Liquid 
C11H22O2 
186.29 
Insoluble 
Freely soluble 
124 (53 hPa) 
 
MS 
95 % 
1.414-1.420 
0.853-0.859 
 
 
09.609 
 
Isopropyl valerate 
 
 
 
18362-97-5 
Liquid 
C8H16O2 
144.21 
Insoluble 
Freely soluble 
165 
 
MS 
95 % 
1.398-1.404 
0.855-0.861 
 
 
09.676 
 
sec-Octyl acetate 
 
 
10799 
2051-50-5 
Liquid 
C10H20O2 
172.27 
Practically insoluble 
or insoluble 
Freely soluble 
193 
 
MS 
95 % 
1.409-1.415 
0.857-0.863 
 
Racemate (EFFA, 2010a). 
09.880 
 
Hept-4-enyl-2 butyrate 
 
 
 
233666-01-8 
Liquid 
C11H20O2 
184.28 
Practically insoluble 
or insoluble 
Freely soluble 
224 
 
MS 
95 % 
1.414-1.420 
0.852-0.858 
 
Racemate of Hept-(4Z)-
enyl-2 butyrate (EFFA, 
2010a). 
Register name to be changed 
to (Z)-4-hepten-2-yl 
butyrate. 
CASrn in Register to be 
changed to 94088-12-7 (Z-
isomer, R,S not specified). 
09.926 
 
Octan-3-yl formate  4009 
 
84434-65-1 
Liquid 
C9H18O2 
158.24 
Practically insoluble 
or insoluble 
Freely soluble 
71 (9 hPa) 
 
IR NMR MS 
1.413-1.417 
0.865-0.875 
 
Racemate (EFFA, 2010a). 
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 7, Revision 4 
FL-no  EU Register name  Structural formula  FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
Specification comments 
98 % 
1)  Solubility in water, if not otherwise stated. 
2)  Solubility in 95%  ethanol, if not otherwise stated. 
3)  At 1013.25 hPa, if not otherwise stated. 
4)  At 20°C, if not otherwise stated. 
5)  At 25°C, if not otherwise stated. 
6)  Stereoisomeric composition not specified. 
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TABLE 2A: SUMMARY OF SAFETY EVALUATION APPLYING THE PROCEDURE (BASED ON INTAKES CALCULATED BY THE MSDI APPROACH) 
Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no  EU Register name  Structural formula  MSDI 1) 
(μg/capita/day
) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5)] 
Outcome on the 
material of 
commerce [6), 7), or 
8)] 
Evaluation remarks 
02.077 
 
Pentan-3-ol  0.19 
 
Class I 
A3: Intake below threshold 
4) 6)   
02.124 
 
6-Methylhept-5-en-2-ol  0.0061 
 
Class I 
A3: Intake below threshold 
4) 6)   
02.142 
 
3,3-Dimethylbutan-2-ol 
 
0.24 
 
Class I 
A3: Intake below threshold 
4) 6)   
02.148 
 
Dodecan-2-ol  0.35 
 
Class I 
A3: Intake below threshold 
4) 6)   
02.177 
 
2-Methylhexan-3-ol  0.12 
 
Class I 
A3: Intake below threshold 
4) 6)   
02.182 
 
3-Methylpentan-2-ol  0.12 
 
Class I 
A3: Intake below threshold 
4) 6)   
02.183 
 
4-Methylpentan-2-ol  0.0012 
 
Class I 
A3: Intake below threshold 
4) 6)   
02.190 
 
Nonan-3-ol  0.011 
 
Class I 
A3: Intake below threshold 
4) 6)   
02.255 
 
(Z)-4-Hepten-2-ol  0.03 
 
Class I 
A3: Intake below threshold 
4) 7)   
07.084 
 
Pentan-3-one  0.24 
 
Class I 
A3: Intake below threshold 
4) 6)   
07.178 
 
3-Methylbutan-2-one 
 
0.073 
 
Class I 
A3: Intake below threshold 
4) 6)   
07.239 [R-(E)]-5-Isopropyl-8-
methylnona-6,8-dien-2-one 
0.24 
 
Class I 
A3: Intake below threshold 
4) 6)   
09.304 
 
sec-Heptyl isovalerate  0.0012 
 
Class I 
A3: Intake below threshold 
4) 6)   
OH
OH
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Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no  EU Register name  Structural formula  MSDI 1) 
(μg/capita/day
) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5)] 
Outcome on the 
material of 
commerce [6), 7), or 
8)] 
Evaluation remarks 
09.323 
 
sec-Butyl acetate  0.0012 
 
Class I 
A3: Intake below threshold 
4) 6)   
09.325 
 
sec-Butyl butyrate  1.3 
 
Class I 
A3: Intake below threshold 
4) 6)   
09.328 
 
sec-Butyl formate  0.12 
 
Class I 
A3: Intake below threshold 
4) 6)   
09.332 
 
sec-Butyl hexanoate  0.024 
 
Class I 
A3: Intake below threshold 
4) 6)   
09.386 
 
sec-Hept-4(cis)-enyl acetate  0.024 
 
Class I 
A3: Intake below threshold 
4) 6)   
09.388 
 
sec-Heptyl acetate  0.12 
 
Class I 
A3: Intake below threshold 
4) 6)   
09.391 
 
sec-Heptyl hexanoate  0.12 
 
Class I 
A3: Intake below threshold 
4) 6)   
09.604 
 
Isopropyl decanoate  0.12 
 
Class I 
A3: Intake below threshold 
4) 6)   
09.605 
 
Isopropyl dodecanoate  0.12 
 
Class I 
A3: Intake below threshold 
4) 6)   
09.606 
 
Isopropyl hexadecanoate  0.012 
 
Class I 
A3: Intake below threshold 
4) 6)   
09.608 
 
Isopropyl octanoate  1.3 
 
Class I 
A3: Intake below threshold 
4) 6)   
09.609 
 
Isopropyl valerate  0.012 
 
Class I 
A3: Intake below threshold 
4) 6)   
09.676 
 
sec-Octyl acetate  0.011 
 
Class I 
A3: Intake below threshold 
4) 6)   
09.880 
 
Hept-4-enyl-2 butyrate  0.79 
 
Class I 
A3: Intake below threshold 
4) 6)   
09.926 
 
Octan-3-yl formate  0.24 
 
Class I 
A3: Intake below threshold 
4) 6)   
O
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Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no  EU Register name  Structural formula  MSDI 1) 
(μg/capita/day
) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5)] 
Outcome on the 
material of 
commerce [6), 7), or 
8)] 
Evaluation remarks 
02.145 
 
2,6-Dimethylocta-1,5,7-trien-3-ol 0.0085 
 
Class II 
A3: Intake below threshold 
4) 6)  a) 
02.194 
 
Octa-1,5-dien-3-ol  0.061 
 
Class II 
A3: Intake below threshold 
4) 7)  a) 
02.211 
 
Undeca-1,5-dien-3-ol  0.061 
 
Class II 
A3: Intake below threshold 
4) 7)  a) 
07.072 
 
6-Methylheptan-3-one  0.19 
 
Class II 
A3: Intake below threshold 
4) 6)   
07.150 
 
Decan-2-one  0.52 
 
Class II 
A3: Intake below threshold 
4) 6)   
07.156 
 
2,6-Dimethyloct-6-en-3-one 0.0012 
 
Class II 
A3: Intake below threshold 
4) 7)   
07.157 
 
6,10-Dimethylundecan-2-one 0.085 
 
Class II 
A3: Intake below threshold 
4) 6)   
07.158 
 
Dodecan-2-one  0.73 
 
Class II 
A3: Intake below threshold 
4) 6)   
07.160 
 
Heptadecan-2-one  0.12 
 
Class II 
A3: Intake below threshold 
4) 6)   
07.162 
 
Hex-5-en-2-one  0.049 
 
Class II 
A3: Intake below threshold 
4) 6)   
07.181 
 
6-Methylheptan-2-one  0.0012 
 
Class II 
A3: Intake below threshold 
4) 6)   
07.185 
 
3-Methylpentan-2-one  1.2 
 
Class II 
A3: Intake below threshold 
4) 6)   
07.189 
 
Nonan-4-one  0.52 
 
Class II 
A3: Intake below threshold 
4) 6)   
07.198 
 
Pseudo-ionone  0.12 
 
Class II 
A3: Intake below threshold 
4) 6)  a) 
OH
OH
OH
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Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no  EU Register name  Structural formula  MSDI 1) 
(μg/capita/day
) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5)] 
Outcome on the 
material of 
commerce [6), 7), or 
8)] 
Evaluation remarks 
07.199 
 
Tetradecan-2-one  0.073 
 
Class II 
A3: Intake below threshold 
4) 6)   
07.201 
 
Tridec-12-en-2-one  0.024 
 
Class II 
A3: Intake below threshold 
4) 6)   
07.204 
 
3,3,6-Trimethylhepta-1,5-dien-4-
one 
0.012 
 
Class II 
A3: Intake below threshold 
4) 6)  a) 
07.205 
 
6,10,14-Trimethylpentadecan-2-
one 
0.0073 
 
Class II 
A3: Intake below threshold 
4) 6)   
07.236 
 
5-Octen-2-one  0.0097 
 
Class II 
A3: Intake below threshold 
4) 6)   
07.262 
 
9-Decen-2-one  73 
 
Class II 
A3: Intake below threshold 
4) 6)   
07.182 
 
5-Methylheptan-3-one 
 
0.32 
 
Class II 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  b) 
1)  EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2)  Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
3)  Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
4)  No safety concern based on intake calculated by the MSDI approach of the named compound. 
5)  Data must be available on the substance or closely related substances to perform a safety evaluation. 
6)  No safety concern at estimated level of intake of the material of commerce meeting the specification of Table 1 (based on intake calculated by the MSDI approach). 
7)  Tentatively regarded as presenting no safety concern (based on intake calculated by the MSDI approach) pending further information on the purity of the material of commerce and/or information on stereoisomerism. 
8)  No conclusion can be drawn due to lack of information on the purity of the material of commerce. 
a)  Evaluated in FGE.206, genotoxicity concern could be ruled out. 
b)  NOAEL for neurotoxicity: 82 mg/kg bw/day; Adequate Margin of Safety. 
 
O
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TABLE 2B: EVALUATION STATUS OF HYDROLYSIS PRODUCTS OF CANDIDATE ESTERS  
Table 2b: Evaluation Status of Hydrolysis Products of Candidate Esters 
FL-no  EU Register name 
JECFA no 
Structural formula  SCF status 1) 
JECFA status 2) 
CoE status 3) 
EFSA status 
Structural class 4) 
Procedure path (JECFA) 5) 
Comments 
 4-Hepten-2-ol 
 
Not evaluated as flavouring substance    Not in EU-Register. 
 Hexadecanoic  acid 
OH
O
 
Not evaluated as flavouring substance    Not in EU-Register. 
02.022 Octan-2-ol 
289 
 
Category 1 a) 
Bev.: -       Food: 25      Exc.: - 
Category B b) 
 
Class I 
A3: Intake below threshold 
 
02.045 Heptan-2-ol 
284 
 
Category 1 a) 
Bev.: -       Food: 25      Exc.: - 
Category B b) 
 
Class I 
A3: Intake below threshold 
 
02.079 Isopropanol 
277 
 
Category 1 a) 
 
 
 
Class I 
A3: Intake above threshold, A4: 
Endogenous 
 
02.098 Octan-3-ol 
291 
 
Category 2 a) 
 
 
 
Class I 
A3: Intake below threshold 
 
02.121 Butan-2-ol 
 
 
Category 1 a) 
 
 
 
 
No evaluation 
 
08.001 Formic  acid 
79    Category 1 a) 
 
Deleted b) 
 
Class I 
A3: Intake below threshold 
 
08.002 Acetic  acid 
81 
 
Category 1 a) 
 
Category A b) 
 
Class I 
A3: Intake above threshold, A4: 
Endogenous 
 
08.005 Butyric  acid 
87 
 
Category 1 a) 
 
Category A b) 
 
Class I 
A3: Intake above threshold, A4: 
Endogenous 
 
OH
(E)- isomer shown
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Table 2b: Evaluation Status of Hydrolysis Products of Candidate Esters 
FL-no  EU Register name 
JECFA no 
Structural formula  SCF status 1) 
JECFA status 2) 
CoE status 3) 
EFSA status 
Structural class 4) 
Procedure path (JECFA) 5) 
Comments 
08.007 Valeric  acid 
90 
 
Category 1 a) 
 
Category A b) 
 
Class I 
A3: Intake below threshold 
 
08.008 3-Methylbutyric  acid 
259 
 
Category 1 a) 
 
Category A b) 
 
Class I 
A3: Intake below threshold 
 
08.009 Hexanoic  acid 
93 
 
Category 1 a) 
 
Category A b) 
 
Class I 
A3: Intake above threshold, A4: 
Endogenous 
 
08.010 Octanoic  acid 
99 
 
Category 1 a) 
 
Category A b) 
 
Class I 
A3: Intake above threshold, A4: 
Endogenous 
 
08.011 Decanoic  acid 
105 
 
Category 1 a) 
 
Category A b) 
 
Class I 
A3: Intake below threshold 
 
08.012 Dodecanoic  acid 
111 
 
Category 1 a) 
 
Category A b) 
 
Class I 
A3: Intake below threshold 
 
1)  Category 1: Considered safe in use   Category 2: Temporarily considered safe in use   Category 3: Insufficient data to provide assurance of safety in use   Category 4): Not acceptable due to evidence of toxicity. 
2)  No safety concern at estimated levels of intake. 
3)  Category A: Flavouring substance, which may be used in foodstuffs Category B: Flavouring substance which can be used provisionally in foodstuffs. 
4)  Threshold of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
5)  Procedure path A substances can be predicted to be metabolised to innocuous products. Procedure path B substances cannot. 
a) (SCF,  1995). 
b) (CoE,  1992). 
ND: Not detected. 
OH
O
OH
O
O
OH
OH
O
OH
O
OH
OFlavouring Group Evaluation 07, Revision 4
 
EFSA Journal 2012;10(10):2899  35
TABLE 3: SUPPORTING SUBSTANCES SUMMARY 
Table 3: Supporting Substances Summary 
FL-no  EU Register name  Structural formula  FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(μg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
02.022 Octan-2-ol 
 
2801 
71 
123-96-6 
289 
JECFA specification (JECFA, 
1998b) 
11  Category 1 a) 
Bev.: -       Food: 25      
Exc.: - 
Category B b) 
JECFA evaluated 2-
octanol (CASrn as in 
Register). (R)- or (S)- 
enantiomer not specified 
by CASrn in Register. 
02.044 Heptan-3-ol 
 
3547 
544 
589-82-2 
286 
JECFA specification (JECFA, 
1998b) 
0.12  Category 2 a) 
Bev.: -       Food: 25      
Exc.: - 
Category B b) 
JECFA evaluated 3-
heptanol (CASrn as in 
Register). (R)- or (S)- 
enantiomer not specified 
by CASrn in Register. 
02.045 Heptan-2-ol 
 
3288 
554 
543-49-7 
284 
JECFA specification (JECFA, 
1998b) 
6.8  Category 1 a) 
Bev.: -       Food: 25      
Exc.: - 
Category B b) 
JECFA evaluated 2-
heptanol (CASrn as in 
Register). (R)- or (S)- 
enantiomer not specified 
by CASrn in Register. 
02.079 Isopropanol 
 
2929 
 
67-63-0 
277 
JECFA specification (JECFA, 
1998b) 
84000  Category 1 a) 
 
 
 
02.081 2,6-Dimethylheptan-4-ol 
 
3140 
11719 
108-82-7 
303 
JECFA specification (JECFA, 
1998b) 
ND  Category 2 a) 
 
 
 
02.086 Undecan-2-ol 
 
3246 
11826 
1653-30-1 
297 
JECFA specification (JECFA, 
1998b) 
0.24  Category 1 a) 
 
 
JECFA evaluated 2-
undecanol (CASrn as in 
Register). (R)- or (S)- 
enantiomer not specified 
by CASrn in Register. 
02.087 Nonan-2-ol 
 
3315 
11803 
628-99-9 
293 
JECFA specification (JECFA, 
1998b) 
0.61  Category 1 a) 
 
 
JECFA evaluated 2-
nonanol (CASrn as in 
Register). (R)- or (S)- 
enantiomer not specified 
by CASrn in Register. 
02.088 Pentan-2-ol 
 
3316 
11696 
6032-29-7 
280 
JECFA specification (JECFA, 
1998b) 
5.4  Category 1 a) 
 
 
JECFA evaluated 2-
pentanol (CASrn as in 
Register). (R)- or (S)- 
enantiomer not specified 
by CASrn in Register. 
02.089 Hexan-3-ol 
 
3351 
11775 
623-37-0 
282 
JECFA specification (JECFA, 
1998b) 
11  Category 2 a) 
 
 
JECFA evaluated 3-
hexanol (CASrn as in 
Register). (R)- or (S)- 
enantiomer not specified 
by CASrn in Register. 
02.098 Octan-3-ol  3581 
11715 
291 
JECFA specification (JECFA, 
4.7  Category 2 a) 
 
JECFA evaluated 3-
octanol (CASrn as in 
OH
OH
OH
OH
OH
OH
OH
OH
OH
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Table 3: Supporting Substances Summary 
FL-no  EU Register name  Structural formula  FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(μg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
589-98-0 1998b)    Register). (R)- or (S)- 
enantiomer not specified 
by CASrn in Register. 
02.103 Decan-3-ol 
 
3605 
10194 
1565-81-7 
295 
JECFA specification (JECFA, 
1998b) 
ND  Category 2 a) 
 
 
JECFA evaluated 3-
decanol (CASrn as in 
Register). (R)- or (S)- 
enantiomer not specified 
by CASrn in Register. 
02.111 3-Methylbutan-2-ol 
 
3703 
 
598-75-4 
300 
JECFA specification (JECFA, 
2000d) 
0.49  Category 2 a) 
 
 
JECFA evaluated 3-
methyl-2-butanol 
(CASrn as in Register). 
(R)- or (S)- enantiomer 
not specified by CASrn 
in Register. 
02.252 4,8-Dimethyl-3,7-nonadien-2-
ol 
 
4102 
 
67845-50-5 
1841 
JECFA specification (JECFA, 
2009b). 
3.0  
 
 
 
07.002 Heptan-2-one 
 
2544 
136 
110-43-0 
283 
JECFA specification (JECFA, 
1998b) 
96  Category 1 a) 
 
Category A b) 
 
07.003 Heptan-3-one 
 
2545 
137 
106-35-4 
285 
JECFA specification (JECFA, 
1998b) 
3.3  Category 2 a) 
 
Category B b) 
 
07.015 6-Methylhept-5-en-2-one 
 
2707 
149 
110-93-0 
1120 
JECFA specification (JECFA, 
2002d). 
100  
 
Category B b) 
 
07.016 Undecan-2-one 
 
3093 
150 
112-12-9 
296 
JECFA specification (JECFA, 
1998b) 
330  Category 1 a) 
 
Category A b) 
 
07.017 4-Methylpentan-2-one 
 
2731 
151 
108-10-1 
301 
JECFA specification (JECFA, 
1998b) 
6.1  
 
Category B b) 
 
07.019 Octan-2-one 
 
2802 
153 
111-13-7 
288 
JECFA specification (JECFA, 
1998b) 
93  Category 1 a) 
 
Category A b) 
 
07.020 Nonan-2-one 
 
2785 
154 
821-55-6 
292 
JECFA specification (JECFA, 
1998b) 
320  Category 1 a) 
 
Category A b) 
 
07.050 Acetone 
 
3326 
737 
67-64-1 
139 
JECFA specification (JECFA, 
1998b) 
6100  Category 1 a) 
 
Category A b) 
 
07.053 Butan-2-one 
 
2170 
753 
78-93-3 
278 
JECFA specification (JECFA, 
1998b) 
96  Category 1 a) 
 
Category A b) 
 
07.054 Pentan-2-one 
 
2842 
754 
107-87-9 
279 
JECFA specification (JECFA, 
1998b) 
120  Category 1 a) 
 
Category A b) 
 
OH
OH
OH
O
O
O
O
O
O
O
O
O
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Table 3: Supporting Substances Summary 
FL-no  EU Register name  Structural formula  FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(μg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
07.058 Heptan-4-one 
 
2546 
2034 
123-19-3 
287 
JECFA specification (JECFA, 
1998b) 
1.9  Category 2 a) 
 
Category B b) 
 
07.062 Octan-3-one 
 
2803 
2042 
106-68-3 
290 
JECFA specification (JECFA, 
1998b) 
2.8  Category 2 a) 
 
Category B b) 
 
07.069 Tetrahydro-pseudo-ionone 
 
3059 
2053 
4433-36-7 
1121 
JECFA specification (JECFA, 
2002d). 
0.012  
 
Category B b) 
JECFA evaluated 
3,4,5,6-
tetrahydropseudoionone 
(CASrn as in Register). 
CASrn refers to the 
racemate. 
07.096 Hexan-3-one 
 
3290 
11097 
589-38-8 
281 
JECFA specification (JECFA, 
1998b) 
0.37  Category 2 a) 
 
 
 
07.099 6-Methylhepta-3,5-dien-2-one 
 
3363 
11143 
1604-28-0 
1134 
JECFA specification (JECFA, 
2002d). 
13  
 
 
 
07.100 5-Methylhex-5-en-2-one  3365 
11150 
3240-09-3 
1119 
JECFA specification (JECFA, 
2002d). 
0.24  
 
 
 
07.103 Tridecan-2-one 
 
3388 
11194 
593-08-8 
298 
JECFA specification (JECFA, 
2000d) 
62  Category 1 a) 
 
 
 
07.113 Nonan-3-one 
 
3440 
11160 
925-78-0 
294 
JECFA specification (JECFA, 
1998b) 
0.12  Category 2 a) 
 
 
 
07.114 6,10,14-Trimethylpentadeca-
5,9,13-trien-2-one 
 
3442 
11206 
762-29-8 
1123 
JECFA specification (JECFA, 
2002d). 
0.085  
 
 
JECFA evaluated 
2,6,10-trimethyl-2,6,10-
pentadecatrien-14-one 
(CASrn as in Register). 
(R)- or (S)- enantiomer 
not specified by CASrn 
in Register. 
07.122 2,6-Dimethylheptan-4-one 
 
3537 
11914 
108-83-8 
302 
JECFA specification (JECFA, 
1998b) 
0.18  
 
 
 
07.123 Geranylacetone 
 
3542 
11088 
3796-70-1 
1122 
JECFA specification (JECFA, 
2002d). 
41  
 
 
JECFA evaluated 6,10-
dimethyl-5,9-
undecadien-2-one 
(CASrn as in Register). 
(R)- or (S)- enantiomer 
not specified by CASrn 
in Register. 
O
O
O
O
O
O
O
O
O
(5E), (9E)-isomer shown
O
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Table 3: Supporting Substances Summary 
FL-no  EU Register name  Structural formula  FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(μg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
07.137 Pentadecan-2-one 
 
3724 
11808 
2345-28-0 
299 
JECFA specification (JECFA, 
2000d) 
18  Category 1 a) 
 
 
 
07.151 Decan-3-one 
 
3966 
11056 
928-80-3 
1118 
JECFA specification (JECFA, 
2002d). 
3.0  
 
 
 
07.190 Octa-1,5-dien-3-one 
 
4405 
 
65213-86-7 
1848 
JECFA specification (JECFA, 
2009b). 
0.061  
 
 
 
07.240 2-Methylheptan-3-one  4000 
 
13019-20-0 
1156 
JECFA specification (JECFA, 
2002d). 
3.0  
 
 
 
07.247 (E,E)-3,5-Octadien-2-one 
 
4008 
 
30086-02-3 
1139 
JECFA specification (JECFA, 
2002d). 
3.0  
 
 
JECFA evaluated (E,E)-
3,5-Octadien-2-one 
(CASrn as in Register). 
CASrn in Register to be 
verified. 
07.249 Undecan-6-one 
 
4022 
 
927-49-1 
1155 
JECFA specification (JECFA, 
2002d). 
3.0  
 
 
 
07.256 (3Z)-4,8-Dimethyl-3,7-
nonadiene-2-one 
3969 
 
817-88-9 
1137 
JECFA specification (JECFA, 
2002d). 
6.1  
 
 
 
09.003 Isopropyl  acetate 
 
2926 
193 
108-21-4 
305 
JECFA specification (JECFA, 
1998b) 
35  
 
Category A b) 
No ADI allocated 
(JECFA, 1980a). 
09.041 Isopropyl  butyrate 
 
2935 
267 
638-11-9 
307 
JECFA specification (JECFA, 
1998b) 
6.0  
 
Category A b) 
 
09.062 Isopropyl  hexanoate 
 
2950 
312 
2311-46-8 
308 
JECFA specification (JECFA, 
2001c) 
3.2  
 
Category A b) 
 
09.105 Isopropyl  tetradecanoate  3556 
386 
110-27-0 
311 
JECFA specification (JECFA, 
2000d) 
19  
 
Category B b) 
 
09.123 Isopropyl  propionate 
 
2959 
404 
637-78-5 
306 
JECFA specification (JECFA, 
2001c) 
0.012  
 
Category A b) 
 
09.165 Isopropyl  formate 
 
2944 
503 
625-55-8 
304 
JECFA specification (JECFA, 
2001c) 
0.45  
 
Category A b) 
 
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
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Table 3: Supporting Substances Summary 
FL-no  EU Register name  Structural formula  FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(μg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
09.254 3-Octyl  acetate 
 
3583 
2347 
4864-61-3 
313 
JECFA specification (JECFA, 
1998b) 
0.61  
 
Category B b) 
JECFA evaluated 3-
octyl acetate (CASrn as 
in Register). (R)- or (S)- 
enantiomer not specified 
by CASrn in Register. 
09.415 Isopropyl  isobutyrate  2937 
290 
617-50-5 
309 
JECFA specification (JECFA, 
1998b) 
0.49  
 
Category A b) 
 
09.450 Isopropyl  isovalerate 
 
2961 
445 
32665-23-9 
310 
JECFA specification (JECFA, 
2002d) 
0.24  
 
Category B b) 
 
09.513 Isopropyl  2-methylcrotonate 
 
3229 
10733 
1733-25-1 
312 
JECFA specification (JECFA, 
1998b) 
0.012  
 
 
JECFA evaluated 
isopropyl tiglate (CASrn 
6284-46-4). CASrn in 
Register refers to (E)-
isomer.  
09.539 Oct-3-yl  2-methylcrotonate 
 
3676 
 
94133-92-3 
448 
JECFA specification (JECFA, 
2001c) 
0.012  
 
 
JECFA evaluated 1-
ethylhexyl tiglate 
(CASrn as in Register). 
(R)- or (S)- enantiomer 
not specified by CASrn 
in Register. 
09.657 1-Methylbutyl  acetate 
 
4012 
10761 
626-38-0 
1146 
JECFA specification (JECFA, 
2002d). 
2.9  
 
 
JECFA evaluated 2-
pentyl acetate (CASrn as 
in Register). (R)- or (S)- 
enantiomer not specified 
by CASrn in Register. 
09.658 1-Methylbutyl  butyrate 
 
3893 
10763 
60415-61-4 
1142 
JECFA specification (JECFA, 
2002d). 
0.47  
 
 
JECFA evaluated 2-
pentyl buturate (CASrn 
as in Register). CASrn 
refers to the racemate. 
09.923 Hept-2-yl  butyrate  3981 
 
39026-94-3 
1144 
JECFA specification (JECFA, 
2002d). 
3.0  
 
 
 
09.924 (+/-)-3-Heptyl  acetate  3980 
 
5921-83-5 
1143 
JECFA specification (JECFA, 
2002d). 
3.0  
 
 
 
09.925 Nonan-3-yl  acetate  4007 
 
60826-15-5 
1145 
JECFA specification (JECFA, 
2002d). 
3.0  
 
 
 
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O O
O
O
O
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Table 3: Supporting Substances Summary 
FL-no  EU Register name  Structural formula  FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(μg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
09.936 4,8-Dimethyl-3,7-nonadien-2-
yl acetate 
4103 
 
91418-25-6 
1847 
JECFA specification (JECFA, 
2009b). 
3.0  
 
 
 
1)  EU MSDI: Amount added to food as flavouring substance in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2)  Category 1: Considered safe in use, Category 2: Temporarily considered safe in use, Category 3: Insufficient data to provide assurance of safety in use, Category 4: Not acceptable due to evidence of toxicity. 
3)  No safety concern at estimated levels of intake. 
4)  Category A: Flavouring substance, which may be used in foodstuffs, Category B: Flavouring substance which can be used provisionally in foodstuffs. 
a) (SCF,  1995). 
b) (CoE,  1992). 
ND)  No intake data reported. 
 
O
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ANNEX I: PROCEDURE FOR THE SAFETY EVALUATION 
The approach for a safety evaluation of chemically defined flavouring substances as referred to in 
Commission Regulation (EC) No 1565/2000 (EC, 2000a), named the "Procedure", is shown in schematic 
form in Figure I.1. The Procedure is based on the Opinion of the Scientific Committee on Food expressed on 
2 December 1999 (SCF, 1999a), which is derived from the evaluation Procedure developed by the Joint 
FAO/WHO Expert Committee on Food Additives at its 44
th, 46
th and 49
th meetings (JECFA, 1995; JECFA, 
1996a; JECFA, 1997a; JECFA, 1999b). 
The Procedure is a stepwise approach that integrates information on intake from current uses, structure-
activity relationships, metabolism and, when needed, toxicity. One of the key elements in the Procedure is 
the subdivision of flavourings into three structural classes (I, II, III) for which thresholds of concern (human 
exposure thresholds) have been specified. Exposures below these thresholds are not considered to present a 
safety concern. 
Class I contains flavourings that have simple chemical structures and efficient modes of metabolism, which 
would suggest a low order of oral toxicity. Class II contains flavourings that have structural features that are 
less innocuous, but are not suggestive of toxicity. Class III comprises flavourings that have structural 
features that permit no strong initial presumption of safety, or may even suggest significant toxicity (Cramer 
et al., 1978). The thresholds of concern for these structural classes of 1800, 540 or 90 µg/person/day, 
respectively, are derived from a large database containing data on subchronic and chronic animal studies 
(JECFA, 1996a). 
In Step 1 of the Procedure, the flavourings are assigned to one of the structural classes. The further steps 
address the following questions: 
•  can the flavourings be predicted to be metabolised to innocuous products
8 (Step 2)?  
•  do their exposures exceed the threshold of concern for the structural class (Step A3 and B3)? 
•  are the flavourings or their metabolites endogenous
9 (Step A4)?  
•  does a NOAEL exist on the flavourings or on structurally related substances (Step A5 and B4)? 
In addition to the data provided for the flavouring substances to be evaluated (candidate substances), 
toxicological background information available for compounds structurally related to the candidate 
substances is considered (supporting substances), in order to assure that these data are consistent with the 
results obtained after application of the Procedure.  
The Procedure is not to be applied to flavourings with existing unresolved problems of toxicity. Therefore, 
the right is reserved to use alternative approaches if data on specific flavourings warranted such actions. 
 
                                                      
8 “Innocuous metabolic products”: Products that are known or readily predicted to be harmless to humans at the 
estimated intakes of the flavouring agent” (JECFA, 1997a). 
 
9 “Endogenous substances”: Intermediary metabolites normally present in human tissues and fluids, whether free or 
conjugated; hormones and other substances with biochemical or physiological regulatory functions are not included 
(JECFA, 1997a). Flavouring Group Evaluation 07, Revision 4
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Decision tree structural class 
Can the substance be predicted to be metabolised to innocuous products?
Procedure for Safety Evaluation of Chemically Defined Flavouring Substances 
Do the conditions of use result in an intake greater than the 
threshold of concern for the structural class?
Do the conditions of use result in an intake greater than the  
threshold of concern for the structural class? 
Data must be available on the  
substance or closely related  
substances to perform a safety 
evaluation
Does a NOAEL exist for the substance which provides an adequate 
margin of safety under conditions of intended use, or does a NOAEL 
exist for structurally related substances which is high enough to 
accommodate any perceived difference in toxicity between the 
substance and the related substances? 
Does a NOAEL exist for the substance which provides an adequate 
margin of safety under conditions of intended use, or does a NOAEL 
exist for structurally related substances which is high enough to 
accommodate any perceived difference in toxicity between the 
substance and the related substances? 
  Substance would not be    
expected to be of safety concern
Is the substance or are its metabolites endogenous?
Additional data required 
Step 1. 
Step 2. 
Step A3. 
Step A4. 
Step A5. 
Step B3. 
Step B4.
 Yes  No
 Yes 
 No 
No
No
Yes
No
Yes
Yes
Yes
 No
Figure I.1 Procedure for Safety Evaluation of Chemically Defined Flavouring SubstancesFlavouring Group Evaluation 07, Revision 4
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ANNEX II: USE LEVELS / MTAMDI 
II.1  Normal and Maximum Use Levels 
For each of the 18 Food categories (Table II.1.1) in which the candidate substances are used, Flavour 
Industry reports a “normal use level” and a “maximum use level” (EC, 2000a). According to the Industry the 
”normal use” is defined as the average of reported usages and ”maximum use” is defined as the 95
th 
percentile of reported usages (EFFA, 2002i). The normal and maximum use levels in different food 
categories have been extrapolated from figures derived from 12 model flavouring substances (EFFA, 2004e). 
Table II.1.1 Food categories according to Commission Regulation (EC) No 1565/2000 (EC, 2000a) 
Food category  Description 
01.0  Dairy products, excluding products of category 02.0 
02.0  Fats and oils, and fat emulsions (type water-in-oil) 
03.0  Edible ices, including sherbet and sorbet 
04.1 Processed  fruit 
04.2  Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and legumes), and nuts & seeds 
05.0 Confectionery 
06.0  Cereals and cereal products, incl. flours & starches from roots & tubers, pulses & legumes, excluding bakery 
07.0 Bakery  wares 
08.0  Meat and meat products, including poultry and game 
09.0  Fish and fish products, including molluscs, crustaceans and echinoderms  
10.0  Eggs and egg products 
11.0  Sweeteners, including honey 
12.0  Salts, spices, soups, sauces, salads, protein products, etc. 
13.0  Foodstuffs intended for particular nutritional uses 
14.1  Non-alcoholic ("soft") beverages, excl. dairy products 
14.2  Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts 
15.0 Ready-to-eat  savouries 
16.0  Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not be placed in categories 01.0 - 15.0 
 
The “normal and maximum use levels” are provided by Industry for all 49 candidate substances in the 
present flavouring group (Table II.1.2). 
Table II.1.2 Normal and Maximum use levels (mg/kg) for the candidate substances in FGE.07Rev4 (EFFA, 
2002b; EFFA, 2002f; EFFA, 2007a; EFFA, 2007b; EFFA, 2007k; Flavour Industry, 2006p; Flavour Industry, 
2009m). 
FL-no Food  Categories 
Normal use levels (mg/kg) 
Maximum use levels (mg/kg) 
01.0 02.0 03.0 04.1 04.2 05.0 06.0 07.0 08.0 09.0 10.0 11.0 12.0 13.0 14.1 14.2 15.0 16.0 
02.077 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
02.124 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
02.142 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
02.145 7 
35 
8 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
02.148 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
02.177 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
02.182 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
02.183 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
02.190 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
02.194 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 Flavouring Group Evaluation 07, Revision 4
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Table II.1.2 Normal and Maximum use levels (mg/kg) for the candidate substances in FGE.07Rev4 (EFFA, 
2002b; EFFA, 2002f; EFFA, 2007a; EFFA, 2007b; EFFA, 2007k; Flavour Industry, 2006p; Flavour Industry, 
2009m). 
FL-no Food  Categories 
Normal use levels (mg/kg) 
Maximum use levels (mg/kg) 
01.0 02.0 03.0 04.1 04.2 05.0 06.0 07.0 08.0 09.0 10.0 11.0 12.0 13.0 14.1 14.2 15.0 16.0 
02.211 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
02.255 5 
20 
- 
- 
10 
50 
- 
- 
- 
- 
10 
60 
- 
- 
10 
60 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
5 
20 
2 
10 
10 
40 
- 
- 
- 
- 
07.072 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
07.084 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
07.150 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
07.156 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
- 
- 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
07.157 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
5 
25 
2 
10 
4 
20 
- 
- 
2 
10 
07.158 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
07.160 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
07.162 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
07.178 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
07.181 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
07.182 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
07.185 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
07.189 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
07.198 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
07.199 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
07.201 3 
15 
2 
10 
3 
10 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
07.204 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
07.205 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
- 
- 
4 
20 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
- 
- 
5 
25 
2 
10 
07.236 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
07.239 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
07.262 10 
30 
- 
- 
5 
15 
10 
30 
10 
30 
30 
150 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
10 
50 
5 
25 
10 
50 
- 
- 
30 
150 
09.304 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.323 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.325 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.328 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
2 
25 
09.332 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.386 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.388 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.391 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.604 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.605 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.606  7  5 10 7  - 10 5 10 2  2  -  -  5 10 5 10  20 5 Flavouring Group Evaluation 07, Revision 4
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Table II.1.2 Normal and Maximum use levels (mg/kg) for the candidate substances in FGE.07Rev4 (EFFA, 
2002b; EFFA, 2002f; EFFA, 2007a; EFFA, 2007b; EFFA, 2007k; Flavour Industry, 2006p; Flavour Industry, 
2009m). 
FL-no Food  Categories 
Normal use levels (mg/kg) 
Maximum use levels (mg/kg) 
01.0 02.0 03.0 04.1 04.2 05.0 06.0 07.0 08.0 09.0 10.0 11.0 12.0 13.0 14.1 14.2 15.0 16.0 
35 25 50 35  -  50 25 50 10 10  -  -  25 50 25 50  100  25 
09.608 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
- 
- 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.609 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
- 
- 
5 
25 
09.676 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.880 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
09.926 7 
35 
5 
25 
10 
50 
7 
35 
- 
- 
10 
50 
5 
25 
10 
50 
2 
10 
2 
10 
- 
- 
- 
- 
5 
25 
10 
50 
5 
25 
10 
50 
20 
100 
5 
25 
II.2  mTAMDI Calculations 
The method for calculation of modified Theoretical Added Maximum Daily Intake (mTAMDI) values is 
based on the approach used by SCF up to 1995 (SCF, 1995). The assumption is that a person may consume 
the amount of flavourable foods and beverages listed in Table II.2.1. These consumption estimates are then 
multiplied by the reported use levels in the different food categories and summed up.  
Table II.2.1 Estimated amount of flavourable foods, beverages, and exceptions assumed to be consumed per 
person per day (SCF, 1995) 
Class of product category  Intake estimate (g/day) 
Beverages (non-alcoholic)  324.0 
Foods  133.4 
Exception a: Candy, confectionery  27.0 
Exception b: Condiments, seasonings  20.0 
Exception c: Alcoholic beverages  20.0 
Exception d: Soups, savouries  20.0 
Exception e: Others, e.g. chewing gum  e.g. 2.0 (chewing gum) 
 
The mTAMDI calculations are based on the normal use levels reported by Industry. The seven food 
categories used in the SCF TAMDI approach (SCF, 1995) correspond to the 18 food categories as outlined in 
Commission Regulation (EC) No 1565/2000 (EC, 2000a) and reported by the Flavour Industry in the 
following way (see Table II.2.2): 
•  Beverages (SCF, 1995) correspond to food category 14.1 (EC, 2000a) 
•  Foods (SCF, 1995) correspond to the food categories 1, 2, 3, 4.1, 4.2, 6, 7, 8, 9, 10, 13, and/or 16 
(EC, 2000a) 
•  Exception a (SCF, 1995) corresponds to food category 5 and 11 (EC, 2000a) 
•  Exception b (SCF, 1995) corresponds to food category 15 (EC, 2000a) 
•  Exception c (SCF, 1995) corresponds to food category 14.2 (EC, 2000a) 
•  Exception d (SCF, 1995) corresponds to food category 12 (EC, 2000a) Flavouring Group Evaluation 07, Revision 4
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•  Exception e (SCF, 1995) corresponds to others, e.g. chewing gum. 
Table II.2.2 Distribution of the 18 food categories listed in Commission Regulation (EC) No 1565/2000 (EC, 
2000a) into the seven SCF food categories used for TAMDI calculation (SCF, 1995) 
  Food categories according to Commission Regulation (EC) No1565/2000  Distribution of the seven SCF food categories 
Key Food  category  Food Beverages
  Exceptions 
01.0  Dairy products, excluding products of category 02.0  Food     
02.0  Fats and oils, and fat emulsions (type water-in-oil)  Food     
03.0  Edible ices, including sherbet and sorbet  Food     
04.1 Processed  fruit  Food     
04.2  Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and legumes), 
and nuts & seeds 
Food    
05.0 Confectionery      Exception  a 
06.0  Cereals and cereal products, incl. flours & starches from roots & tubers, pulses & 
legumes, excluding bakery 
Food    
07.0 Bakery  wares  Food     
08.0  Meat and meat products, including poultry and game  Food     
09.0  Fish and fish products, including molluscs, crustaceans and echinoderms   Food     
10.0  Eggs and egg products  Food     
11.0  Sweeteners, including honey      Exception a 
12.0  Salts, spices, soups, sauces, salads, protein products, etc.       Exception d 
13.0  Foodstuffs intended for particular nutritional uses  Food     
14.1  Non-alcoholic ("soft") beverages, excl. dairy products    Beverages   
14.2  Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts      Exception c 
15.0 Ready-to-eat  savouries      Exception  b 
16.0  Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not be 
placed in categories 01.0 - 15.0 
Food    
The mTAMDI values (see Table II.2.3) are presented for each of the 49 flavouring substances in the present 
flavouring group, for which Industry has provided use and use levels (EFFA, 2002b; EFFA, 2002f; EFFA, 
2007a; EFFA, 2007b; EFFA, 2007k; Flavour Industry, 2006p; Flavour Industry, 2009m). The mTAMDI 
values are only given for highest reported normal use levels (see Table II.2.3 and II.2.4). 
Table II.2.3 Estimated intakes based on the mTAMDI approach 
FL-no  EU Register name  mTAMDI 
(μg/person/day) 
Structural class  Threshold of concern 
(µg/person/day) 
02.077 Pentan-3-ol  3900  Class  I  1800 
02.124 6-Methylhept-5-en-2-ol  3900  Class  I  1800 
02.142 3,3-Dimethylbutan-2-ol  3900  Class  I  1800 
02.148 Dodecan-2-ol  3900  Class  I  1800 
02.177 2-Methylhexan-3-ol  3900  Class  I  1800 
02.182 3-Methylpentan-2-ol  3900  Class  I  1800 
02.183 4-Methylpentan-2-ol  3900  Class  I  1800 
02.190 Nonan-3-ol  3900  Class  I  1800 
02.255 (Z)-4-Hepten-2-ol  2500  Class  I  1800 
07.084 Pentan-3-one  1600  Class  I  1800 
07.178 3-Methylbutan-2-one  1600  Class  I  1800 
07.239 [R-(E)]-5-Isopropyl-8-methylnona-6,8-dien-2-one  1600  Class  I  1800 
09.304  sec-Heptyl isovalerate  3900  Class I  1800 
09.323  sec-Butyl acetate  3900  Class I  1800 
09.325  sec-Butyl butyrate  3900  Class I  1800 
09.328  sec-Butyl formate  3900  Class I  1800 
09.332  sec-Butyl hexanoate  3900  Class I  1800 
09.386  sec-Hept-4(cis)-enyl acetate  3900  Class I  1800 
09.388  sec-Heptyl acetate  3900  Class I  1800 
09.391  sec-Heptyl hexanoate  3900  Class I  1800 
09.604  Isopropyl decanoate  3900  Class I  1800 
09.605  Isopropyl dodecanoate  3900  Class I  1800 
09.606  Isopropyl hexadecanoate  3900  Class I  1800 
09.608  Isopropyl octanoate  3900  Class I  1800 
09.609  Isopropyl valerate  3500  Class I  1800 
09.676  sec-Octyl acetate  3900  Class I  1800 
09.880 Hept-4-enyl-2  butyrate  3900  Class  I  1800 
09.926  Octan-3-yl formate  3900  Class I  1800 Flavouring Group Evaluation 07, Revision 4
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Table II.2.3 Estimated intakes based on the mTAMDI approach 
FL-no  EU Register name  mTAMDI 
(μg/person/day) 
Structural class  Threshold of concern 
(µg/person/day) 
02.145 2,6-Dimethylocta-1,5,7-trien-3-ol  3900  Class  II  540 
02.194 Octa-1,5-dien-3-ol  3900  Class  II  540 
02.211 Undeca-1,5-dien-3-ol  3900  Class  II  540 
07.072 6-Methylheptan-3-one  1600  Class  II  540 
07.150 Decan-2-one  1600  Class  II  540 
07.156 2,6-Dimethyloct-6-en-3-one  1600  Class  II  540 
07.157 6,10-Dimethylundecan-2-one  1500  Class  II  540 
07.158 Dodecan-2-one  1600  Class  II  540 
07.160 Heptadecan-2-one  1600  Class  II  540 
07.162 Hex-5-en-2-one  1600  Class  II  540 
07.181 6-Methylheptan-2-one  1600  Class  II  540 
07.185 3-Methylpentan-2-one  1600  Class  II  540 
07.189 Nonan-4-one  1600  Class  II  540 
07.198 Pseudo-ionone  1600  Class  II  540 
07.199 Tetradecan-2-one  1600  Class  II  540 
07.201 Tridec-12-en-2-one  1600  Class  II  540 
07.204 3,3,6-Trimethylhepta-1,5-dien-4-one  1600  Class  II  540 
07.205 6,10,14-Trimethylpentadecan-2-one  1500  Class  II  540 
07.236 5-Octen-2-one  1600  Class  II  540 
07.262 9-Decen-2-one  6600  Class  II  540 
07.182 5-Methylheptan-3-one  1600  Class  II  540 
 Flavouring Group Evaluation 07, Revision 4
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ANNEX III: METABOLISM 
III.1.  General information 
The present flavouring group evaluation consists of 49 candidate substances of which seven are saturated 
aliphatic acyclic secondary alcohols [FL-no: 02.077, 02.142, 02.148, 02.177, 02.182, 02.183 and 02.190]; 
five are unsaturated aliphatic secondary alcohols [FL-no: 02.124, 02.145, 02.194, 02.211 and 02.255] of 
which three contain a terminal double bond [FL-no: 02.145, 02.194 and 02.211]; 13 are saturated aliphatic 
ketones [FL-no: 07.072, 07.084, 07.150, 07.157, 07.158, 07.160, 07.178, 07.181, 07.182, 07.185, 07.189, 
07.199 and 07.205], eight are unsaturated aliphatic ketones [FL-no: 07.156, 07.162, 07.198, 07.201, 07.204, 
07.236, 07.239 and 07.262] of which five contain a terminal double bond [FL-no: 07.162, 07.201, 07.204, 
07.239 and 07.262] and 16 are esters of aliphatic acyclic secondary alcohols and linear aliphatic carboxylic 
acids [FL-no: 09.304, 09.323, 09.325, 09.328, 09.332, 09.386, 09.388, 09.391, 09.604, 09.605, 09.606, 
09.608, 09.609, 09.676, 09.880 and 09.926]. 
The general metabolic reactions that the candidate substances may be expected to undergo, and which are 
discussed below, are one or several of the following:  
•  conjugation of secondary alcohols with glucuronic acid 
•  oxidation of secondary alcohols 
•  reduction of ketones 
•  oxidation of ketones 
•  oxidation of double bonds 
•  oxidation of terminal double bonds 
•  hydrolysis of esters. 
A general discussion on the biotransformation of Saturated Aliphatic Acyclic Secondary Alcohols, Ketones, 
and Related Saturated and Unsaturated Esters may be found in the reports from the 51
st, 59
th and 69
th  
meetings of the JECFA (JECFA, 1999a; JECFA, 2000a; JECFA, 2002c; JECFA, 2003a; JECFA, 2009c). 
The discussions and conclusions related to these supporting substances essentially apply also to the candidate 
substances.  
There is one candidate substance 5-methylheptan-3-one [FL-no: 07.182] that may be oxidised to yield a 
neurotoxic gamma-diketone and therefore it may potentially give rise to concern.  
III.2.  Absorption 
In general aliphatic secondary alcohols and ketones are expected to be rapidly absorbed in the 
gastrointestinal tract (JECFA, 1999a).  
Peak blood levels were obtained 1 to 2 hours (h) after dosing when isopropanol was given orally to rats as 
well as when the same substance was administered intravenously to dogs (Lehman et al., 1945; Nordmann et 
al., 1973a). Peak blood levels were also obtained within 2 hours when 1- and 2-propanol, or 1- and 2- 
isobutanol were given orally to human volunteers together with ethanol (Bonte et al., 1981a).  Flavouring Group Evaluation 07, Revision 4
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In a pharmacokinetic experiment, 2-butanol (2.2 ml/kg bw or 1776 mg/kg bw), 2-butanone (2.1 ml/kg bw or 
1690 mg/kg bw) and 2,3-butanediol (0.68 ml/kg bw or 676 mg/kg bw), respectively, were administered 
orally in aqueous solutions to male Sprague-Dawley rats. Peak blood concentrations after administration of 
0.95 mg/l 2-butanone were detected after 4 h and declined to 0.07 mg/ml after 18 h. The concentrations of 
the metabolites 2,3-butanediol, 2-butanol and 3-hydroxy-2-butanone peaked at 0.26 mg/l, 0.033 mg/l and 
0.027 mg/l at 18 h, 6 h and 8 h, respectively, after 2-butanone administration. Total AUC (Area Under the 
Curve) values for 2-butanone, 2,3-butanediol, 2-butanol and 3-hydroxy-2-butanone were 10.899±824, 
3863±238, 414±38 and 382±38 mg h/l, respectively. Blood concentration after administration of 2-butanol 
peaked after 2 h at 0.59 mg/l and declined to 0.05 mg/l after 16 h. The blood concentrations of 2-butanone, 
3-hydroxy-2-butanone and 2,3-butanediol rose to maximums after 8, 12 and 18 h and were 0.78, 0.04 and 
0.21 mg/l, respectively. Total AUC values were 3254±258 mg h/l for 2-butanol, 9868±566 for 2-butanone, 
443±93 for 3-hydroxy-2-butanone and 3167±503 mg h/l for 2,3-butanediol (Dietz et al., 1981).  
Rats were administered 1 g/kg bw 2-pentanol, 3-pentanol and 3-methyl-2-butanol, via intraperitoneal (ip) 
injection. The alcohols were eliminated within 13 to 16 hours (Haggard et al., 1945).   
III.3.  Metabolism and Elimination 
III.3.1. Secondary Alcohol 
Oxidation and glucuronic acid conjugation 
Secondary alcohols may undergo oxidation to the corresponding ketone. However, this reaction is generally 
unfavoured in vivo, since the alcohol is removed from the equilibrium by conjugation with glucuronic acid, 
which represents the major biotransformation pathway for secondary alcohols (Kasper and Henton, 1980; 
JECFA, 1999a). Glucuronidation is a Phase-II-reaction, which involves the transfer of glucuronic acid in an 
activated form to functional groups of the substrate, in this case to the hydroxyl groups of the molecules. 
This renders highly polar products, for which excretion is facilitated. The reaction is catalysed by UDP-
glucuronyl transferase, which exists in several isoforms with different substrate specificities. The enzymes 
are located in the endoplasmatic reticulum, and are found in most tissues including the liver. The glucuronic 
acid conjugates are primarily excreted in the urine or bile, depending on the relative molecular mass and the 
animal species. For the candidate secondary alcohols, the urine is expected to be the main route of 
elimination. 
III.3.2. Ketones 
In addition to reduction and oxidation pathways, low molecular weight ketones (carbon chain length <5) may 
be excreted unchanged in expired air (Brown et al., 1987). In mammals, oral doses of volatile ketones or 
their corresponding alcohols are mainly eliminated as the ketone in expired air. Lower amounts are excreted 
in the urine (Haggard et al., 1945; Schwartz, 1989; Scopinaro et al., 1947).  
In the rat, 2-pentanone in expired air was the major metabolite following administration of 2-pentanol by 
intraperitoneal injection. Lower amounts of 2-pentanol were also exhaled and both metabolites were detected 
in the urine (Haggard et al., 1945). Similarly, unchanged 2-pentanone administered orally to dogs has been 
identified in the expired air (Schwartz, 1989). 
Reduction of ketones 
In general, the major metabolic pathway for the detoxification and excretion of aliphatic ketones involves 
reduction of the ketone to the corresponding secondary alcohol with subsequent excretion as conjugate of 
glucuronic acid. This reaction is reversible under physiologic conditions, but in vivo the secondary alcohols 
are removed from the equilibrium by conjugation to glucuronic acid, as is stated above, and the reaction 
proceeds to form further secondary alcohols (Felsted and Bachur, 1980; JECFA, 1999a). Reduction of Flavouring Group Evaluation 07, Revision 4
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aliphatic ketones is mediated by alcohol dehydrogenase and NADH/NADPH-dependent cytosolic carbonyl 
reductases (Bosron and Li, 1980). According to Felsted and Bachur (1980) the reaction catalysed by 
carbonyl reductase is stereoselective and favours formation of the (S)-enantiomer of the alcohol (Felsted and 
Bachur, 1980).  
In studies limited to the identification of urinary glucuronide, relatively high single dose levels of a 
homologous series of aliphatic secondary alcohols and ketones were administered individually by gavage to 
rabbits. The urinary excretion of glucuronic acid conjugates was determined after 24 hours (Kamil et al., 
1953a). The substances, dose levels and average urinary output of glucuronide (UGAC) are shown below in 
Table III.1. 
Table III.1 The Urinary Excretion of Glucuronic Acid Conjugates (UGAC, determined after 24 hours) of 
Aliphatic Secondary Alcohols and Ketones After Administration by Gavage to Rabbits (Kamil et al., 1953a). 
Substance  Dose (mg/kg bw)  UGAC (%) 
2-pentanol 735  44.8 
2-heptanone 950  41.0 
2-heptanol 965  54.6 
3-heptanol 965  61.9 
2-octanol 1081  15.5 
 
Oxidation of ketones 
Ketones may also be metabolised via omega- or omega-1-oxidation. Participation in these pathways depends 
on chain length, position of the carbonyl function and dose (Dietz et al., 1981; Topping et al., 1994).  
Short chain ketones (C < 5) that contain a carbonyl function at the C-2 may undergo oxidation of the 
terminal methyl group and subsequent oxidation to yield an alpha-keto carboxylic acid. As intermediary 
metabolites, alpha-keto acids undergo oxidative decarboxylation to yield carbon dioxide and a simple 
aliphatic carboxylic acid, which may be completely metabolised in the fatty acid pathway and citric acid 
cycle. Alternatively, omega-oxidation may occur to yield a hydroxyketone, which may be further reduced to 
a diol, e.g. 2,3-butanediol from butanone, and excreted in the urine as a glucuronic acid conjugate.  
Longer chain aliphatic ketones (carbon chain length ≥ 5) are primarily metabolised via reduction, but omega- 
and omega-1-oxidation are competing pathways at high concentrations (Dietz et al., 1981; Topping et al., 
1994). 
Studies with specific substances 
4-Methylpentan-2-ol [candidate substance FL-no: 02.183] and 4-hydroxy-4-methylpentan-2-one were 
detected in serum after ip injection of 4-methylpentan-2-one to guinea pigs. The half-life and clearance times 
of 4-methylpentan-2-one were 66 minutes and 6 hours, respectively. 4-Hydroxy-4-methylpentan-2-one was 
the principal metabolite and was cleared in 16 hours. The concentration of 4-methylpentan-2-ol [FL-no: 
02.183] was too low for quantification. 4-Methylpentan-2-one is metabolised by reduction of the carbonyl 
group to form the secondary alcohol, 4-methylpentan-2-ol [FL-no: 02.183], and by oxidation at the omega-1 
carbon atom to form the hydroxylated ketone, 4-hydroxy-4-methylpentan-2-one (DiVincenzo et al., 1976). 
Gamma-Diketone formation Flavouring Group Evaluation 07, Revision 4
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Omega-1 oxidation of aliphatic ketones with special structural features may yield neurotoxic gamma-
diketones. The metabolic pathway includes oxidation of the omega-1-carbon, first to a hydroxyketone and 
then to a diketone. The gamma-spacing of the carbonyl functions has been shown to be a prerequisite for 
neurotoxic effects, only ketones with this structural feature may yield the neurotoxic metabolites. One of the 
candidate substances 5-methyl-3-heptanone [FL-no: 07.182], may potentially be oxidised to a gamma-
diketone, 3-methyl-2,5-heptanedione.  
Studies have shown that neurotoxicity of selected ketones is related to a common metabolic pathway leading 
to the formation of a gamma-diketone, which is the metabolite that produces neuropathy. The neurotoxic 
effects show a specific anatomic and morphological type of nerve degeneration characterised by large 
multifocal axonal swellings, referred to as ”giant axonal” neuropathy. Clinical symptomatology in humans 
includes bilaterally symmetrical paresthesia, ”pins and needles” feeling, and muscle weakness, primarily in 
arms and legs. Except for 3,6-octanedione, all metabolic interconversions are oxidation of the omega-1-
carbon, first to a hydroxyketone and then to a gamma-diketone. When the omega-carbon is oxidised in 
preference to the omega-1-carbon, no gamma-diketone is formed (Topping et al., 1994).  
Induction of clear and typical signs of neurotoxicity in male rats dosed with 5-methyl-3-heptanone [FL-no: 
07.182] in a subchronic study supported the hypothesis that a gamma-diketone may be formed as toxic 
metabolite. Adult male rats, 5 per group, were administered 5-methyl-3-heptanone [FL-no: 07.182] by 
gavage five days a week for 13 weeks at doses of 0, 82, 410 and 820 mg/kg bw/day. In addition to clinical 
observations, a Functional Observation Battery (FOB) was conducted. The result of the FOB clearly 
indicated peripheral neuropathy in the highest dose group and similar but less severe deficits were detected 
in the middle dose group. No functional defects were observed in the low-dose group. Gross examination 
showed no treatment related effects at any dose, but microscopic examination of sciatic and tibial nerves 
from the highest dose group revealed lesions typical of ”giant axonal” neuropathy. In the mid-dose group 
some changes were observed that were not necessarily diagnostic of ”giant axonal” neuropathy, but appeared 
to reflect reparative processes in the nerves and may as such have represented a borderline effect. Nerves 
from the low-dose group did not show any evidence of pathology attributable to treatment. The NOAEL for 
methyl-5-heptan-3-one was in this study considered to be 82 mg/kg bw/day (IBM Corp., 1989). 
Data suggest that the neurotoxicity of the diketone decreases as chain length increases, possibly owing to 
steric hindrance. However, chain length may not be important to some materials, as in the case of 5-
nonanone. Another factor modifying the neurotoxic potential of these substances is the number and size of 
substituent groups located between the gamma-spaced carbonyls. Single methyl groups on the carbons 
located between the carbonyl groups increase the potential neurotoxicity, whereas two methyl groups 
positioned on one of the carbon atoms between the carbonyls eliminate neurotoxicity (Topping et al., 1994). 
Among the supporting substances, 3-heptanone [FL-no: 07.003], 2-methylheptan-3-one [FL-no: 07.240], 3-
heptanol [FL-no: 02.044] and 3-heptyl acetate [FL-no: 09.924] are the only substances that may be 
metabolised to yield neurotoxic gamma-diketones (Topping et al., 1994). The neurotoxicity for these 
substances is observed only at high doses.  
In a study reported as a meeting abstract, aliphatic ketones (hexane-2-one, pentane-3-one, heptane-3-one, 4-
methyl-2-pentanone and 3,3-dimethyl-2-butanone) were administered in drinking water to female Wistar 
rats. It was concluded that administration of approximately 1 g/kg bw/day of hexane-2-one for 120 days 
produced muscle weakness, atrophy and peripheral neuropathy. None of the other ketones produced 
significant neurological alterations (Homan and Maronpot, 1978). 
In an oral gavage study Crl rats, 2 per group, were given 3-heptanone [FL-no: 07.003] (0.25, 0.5, 1 or 2 g/kg 
bw/day, for 5 days/week for 14 weeks. The highest dose-group (approaching the LD50 value in rats = 2760 
mg/kg bw) was the only one developing treatment-related neuropathologic lesions of typical ”giant-axonal” 
type. No neuropathology was observed in the lower dose groups (O’Donoghue et al., 1984). This study 
determined that 3-heptanone has a low neurotoxic potential; however when its intake was combined with Flavouring Group Evaluation 07, Revision 4
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methyl ethyl ketone, neurotoxic effects were potentiated, by stimulating 3-heptanone metabolism to 2,5-
heptandione, a neurotoxic gamma-diketone (O’Donoghue et al.,  1984). 
III.3.3 Oxidation of terminal double bonds in secondary alkohols and in ketones 
Eight of the candidate substances [FL-no: 02.145, 02.194, 02.211, 07.162, 07.201, 07.204, 07.239 and 
07.262] contain terminal double bonds. These double bonds may be oxidised to the corresponding epoxides. 
Epoxides are highly reactive molecules due to the large strain associated with the three membered ring 
structure, and they react easily with nucleophilic sites of cellular macromolecules. For this reason, several 
aliphatic alkene-derived epoxides (e.g. ethylene, isoprene, butadiene and glycidol) have been demonstrated 
to be carcinogenic (Melnick, 2002). However, epoxides can be conjugated with glutathione by glutathione S-
transferases or hydrolysed to diols by epoxide hydrolases. The latter two reactions can be considered to be 
detoxications. 1-Alkenes are metabolised by P450 through both double bond oxidation to the corresponding 
epoxide and allylic oxidation (Chiappe et al., 1998). The rates of the two reactions measured with different 
P450 isoforms indicate that epoxide formation is generally favoured (Chiappe et al., 1998). Therefore, due to 
the similar position of the double bond, it cannot be ruled out that, in addition to the above mentioned 
metabolic pathways for alcohols and ketones, the eight candidate substances [FL-no: 02.145, 02.194, 02.211, 
07.162, 07.201, 07.204, 07.239 and 07.262] may be, at least partially, biotransformed to an epoxide. 
However, based on the low levels of intake of unsaturated secondary alcohols and of alkenones characterised 
by an alcohol or a carbonyl group in a distant position to the terminal double bond, it is expected that the 
detoxication reactions would not be saturated and would outweigh the rate of epoxide formation. The 
presence of the terminal double bond in these candidate substances is therefore not considered of concern 
because epoxides can be detoxicated by conjugation with glutathione or by epoxide hydrolase mediated 
hydrolysis. 
Furthermore, based on genotoxicity data available for seven out of 48 flavouring substances with terminal 
double bonds from the Register (EC, 1999a; EC, 2004a), it is not indicated that a terminal double bond distal 
to a functional group is a structural alert for genotoxicity. 
III.4.  Ester Hydrolysis 
The aliphatic esters among the candidate substances are expected to be hydrolysed to their component 
secondary alcohols and carboxylic acids. The carboxylesterase or esterase classes of enzymes, the most 
important of which are the beta-esterases, catalyse ester hydrolysis (Heymann, 1980). In mammals these 
enzymes occur within the body in most tissues including the gut lumen and intestinal wall, but predominate 
in the hepatocytes (Heymann, 1980). The wide range of tissue distribution and the multiplicity of esterases 
generally give rise to rapid hydrolysis of esters in vivo.  
There are no hydrolysis studies on the candidate substances, but there are in vitro hydrolysis data for 
structurally related esters.  
In vitro hydrolysis studies of esters have been performed with specific carboxylesterase isoenzymes isolated 
from pig and rat livers (Arndt and Krisch, 1973; Junge and Heymann, 1979). The isoenzyme I exhibits an 
increase in enzyme binding (lower Km) and maximum velocity (Vmax) as the carbon chain length of either the 
alcohol or carboxylic acid component of the substrate increases. It is also shown that different isoenzymes 
show great differences in the hydrolysis rates. Isoenzyme V had an optimum for the C5 compound, while 
this isoenzyme exhibited a minimum activity with the butyl and pentyl acetates. Results of in vitro studies 
indicate that the rate of hydrolysis of straight-chain esters is approximately 100 times faster than the rate of 
hydrolysis of branched-chain esters.  
Incubation of isopropyl butanoate, isopropyl phenylacetate, isoamyl acetate and isoamyl phenylacetate with 
pancreatin produced 40, 50, 20, and 100 % hydrolysis respectively, after 2 hours (Grundschober, 1977; Flavouring Group Evaluation 07, Revision 4
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Leegwater and Straten, 1974a). Also, isoamyl acetate incubated with intestinal mucosa homogenates 
obtained from pigs demonstrated complete hydrolysis (Grundschober, 1977; Leegwater and Straten, 1974b).  
Esters formed from aliphatic secondary alcohols were hydrolysed to their corresponding alcohols and 
carboxylic acids when incubated with liver homogenates or small intestinal homogenates obtained from male 
Wistar albino rats, artificial gastric juice or artificial pancreatic juice with half-lives ranging from less than 
one second to several hours depending on the incubation medium (Gangolli and Shilling, 1968; Longland et 
al., 1977). Rat liver homogenates and small intestinal preparations were found to be much more efficient 
than artificial pancreatic juice for hydrolysis of a variety of aliphatic esters. Also, hydrolysis in simulated 
intestinal fluid with pancreatin was much faster than in simulated gastric juice (Longland et al., 1977).  
The data on substances structurally related to the candidate substances indicate that hydrolysis is the major 
pathway for the candidate substances that are esters of secondary alcohols, and that they will be hydrolysed 
to their component alcohols and carboxylic acids within a relatively short time. 
III.5.  Conclusion 
In conclusion, it may be anticipated that the seven saturated aliphatic acyclic secondary alcohols [FL-no: 
02.077, 02.142, 02.148, 02.177, 02.182, 02.183 and 02.190], the five unsaturated aliphatic secondary 
alcohols [FL-no: 02.124, 02.145, 02.194, 02.211 and 02.255], the 12 of the 13 saturated aliphatic ketones 
[FL-no: 07.072, 07.084, 07.150, 07.157, 07.158, 07.160, 07.178, 07.181, 07.185, 07.189, 07.199 and 
07.205], the eight unsaturated aliphatic ketone [FL-no: 07.156, 07.162, 07.198, 07.201, 07.204, 07.236, 
07.239 and 07.262] and the 16 esters of aliphatic acyclic secondary alcohols and linear aliphatic carboxylic 
acids [FL-no: 09.304, 09.323, 09.325, 09.328, 09.332, 09.386, 09.388, 09.391, 09.604, 09.605, 09.606, 
09.608, 09.609, 09.676, 09.880 and 09.926] may be expected to be metabolised to innocuous substances at 
the estimated levels of intake as flavouring substances.  
One candidate substance, 5-methyl-3-heptanone [FL-no: 07.182], may be oxidised to a potentially neurotoxic 
gamma-diketone, 3-methyl-2,5-heptanedione.  Flavouring Group Evaluation 07, Revision 4
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ANNEX IV: TOXICITY 
Oral acute toxicity data are available for 12 candidate substances of the present Flavouring Group Evaluation from chemical group 5, and for 23 supporting 
substances evaluated by the JECFA at the 51
st and 59
th meetings (JECFA, 1999a; JECFA, 2003a). The supporting substances are listed in brackets. 
Table IV.1: Acute toxicity 
Chemical Name [FL-no]  Species  Sex  LD50 
(mg/kg bw) 
Reference 
(Acetone [07.050])  Rat  M  8452  (Smyth et al., 1970) 
Rat  NR  8930  (Smyth et al., 1969b) 
Rat NR  9750  (FDA,  1975a) 
Rat  NR  6800  (Kimura et al., 1971a) 
Rat  NR  3465  (Kohli et al., 1967) 
Mouse  M  5250  (Tanii et al., 1986) 
Rabbit  NR  5300  (Krasavage et al., 1982) 
(Isopropyl alcohol [02.079])  Rat  NR  5840  (Smyth and Carpenter, 1948) 
Rat  NR  5280  (Lehman and Chase, 1944) 
Rat  NR  5300  (Kimura et al., 1971a) 
Rat NR  5330  (FDA,  1975a) 
Mouse NR  5070  (FDA,  1975a) 
Rabbit  NR  5040  (Lehman and Chase, 1944) 
Rabbit NR  7990  (Munch,  1972) 
Dog  NR  4830  (Lehman and Chase, 1944) 
(2-Butanone [07.053])  Rat  M  5490  (Smyth et al., 1962) 
Rat  NR  2730  (Kimura et al., 1971a) 
Rat  NR  3980  (Union Carbide Corp., 1956) 
Rat  F  5525  (Pozzani et al., 1959) 
Mouse  M  3137  (Zakhari et al., 1977) 
Mouse  M  4050  (Tanii et al., 1986) 
(2-Pentanone [07.054])  Rat  M  3730  (Smyth et al., 1962) 
Mouse  M  2205  (Tanii et al., 1986) 
(2-Pentanol [02.088])  Rabbit  NR  2820  (Munch, 1972) 
Pentan-3-one [07.084]  Rat  NR  2900  (BASF, 1969) 
Rat  NR  2140  (Panson and Winek, 1980) 
Rat  NR  2140  (Eder et al., 1982a) 
Rat NR  2140  (Kennedy  and Graepel, 1991) Flavouring Group Evaluation 07, Revision 4
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Table IV.1: Acute toxicity 
Chemical Name [FL-no]  Species  Sex  LD50 
(mg/kg bw) 
Reference 
Rat  NR  3100  (Ibatullina and Larionova, 1997) 
Pentan-3-ol [02.077]  Rat  NR  1870  (Eder et al., 1982a) 
(3-Hexanone [07.096])  Rat  NR  2727  (Carpenter et al., 1974) 
(2-Heptanone [07.002])  Rat  M  1670  (Smyth et al., 1962) 
Mouse  M  2407  (Tanii et al., 1986) 
Mouse  NR  1088  (Schafer and Bowles, 1985) 
Mouse  NR  730  (Srepel and Akacic, 1962) 
(2-Heptanol [02.045])  Rat  M, F  2580  (Eder et al., 1982a) 
(3-Heptanone [07.003])  Rat  NR  2760  (Smyth et al., 1949) 
(3-Heptanol [02.044])  Rat  NR  1870  (Smyth et al., 1951a) 
(4-Heptanone [07.058])  Rat  NR  3049  (Carpenter et al., 1974) 
(2-Octanone [07.019])  Mouse  M  3823  (Tanii et al., 1986) 
Mouse  NR  3870  (Tanii et al., 1986) 
(2-Nonanone [07.020])  Mouse  M  7992  (Tanii et al., 1986) 
Decan-2-one [07.150]  Mouse  M  7936  (Tanii et al., 1986) 
(2-Undecanone [07.016])  Mouse  NR  950  (Schafer and Bowles, 1985) 
Mouse  M  5460  (Tanii et al., 1986) 
Methyl-3-butan-2-one [07.178]  Mouse  M  2572  (Tanii et al., 1986) 
Rat NR  148  (Kennedy  and Graepel, 1991) 
(4-Methyl-2-pentanone [07.017])  Rat  NR  2080  (Smyth et al., 1951a) 
Mouse  M  2670  (Tanii et al., 1986) 
Mouse  NR  1200  (McOmie and Anderson, 1949a) 
Methyl-4-pentan-2-ol [02.183] 
 
Rat  NR  2590  (Smyth et al., 1951a) 
Mouse  NR  1500  (McOmie and Anderson, 1949a) 
Methyl-6-heptan-2-one [07.181]  Rat  NR  6700  (BASF, 1975) 
Methyl-5-heptan-3-one [07.182]  Rat  NR  3500  (Kennedy and Graepel, 1991) 
(2,6-Dimethyl-4-heptanone [07.122])  Rat  NR  5750  (Smyth et al., 1949) 
Mouse  NR  2800  (McOmie and Anderson, 1949a) 
Mouse NR  1416  (RTECS,  1975) 
Trimethyl-6,10,14-pentadecan-2-one [07.205]  Rat  NR  >2000  (BASF, 1988) 
(6-Methyl-5-hepten-2-one [07.015])  Mouse  M, F  3609  (Colaianni, 1967) 
Rat  M, F  4100  (Keating, 1972a) 
(3,4,5,6-Tetra-hydropseudoionone [07.069])  Mouse  M, F  5200  (Moreno, 1982a) Flavouring Group Evaluation 07, Revision 4
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Table IV.1: Acute toxicity 
Chemical Name [FL-no]  Species  Sex  LD50 
(mg/kg bw) 
Reference 
Rat  M, F  >5000  (Moreno, 1977a) 
(6,10-Dimethyl-5,9-undecadien-2-one [07.123])  Mouse  M, F  8650  (Moreno, 1976b) 
Rat  M, F  >6800  (Hofmann, 1978a) 
(2,6,10-Trimethyl-2,6,10-pentadecatrien-14-one 
[07.114]) 
Rat  M, F  >5000  (deGroot et al., 1974) 
(Isopropyl formate [09.165])  Rat  NR  4300  (FDA, 1975a) 
Rabbit NR  2500  (FDA,  1975a) 
Guinea Pig  NR  2700  (FDA, 1975a) 
Chicken NR  2100  (FDA,  1975a) 
(Isopropyl acetate [09.003])  Rat  M, F  6750  (Eder et al., 1982a) 
Rat NR  3000  (FDA,  1975a) 
Rabbit NR  6945  (Munch,  1972) 
Isopropyl hexadecanoate [09.606]  Rat  M, F  >40000  (Food and Drug Research Laboratories, Inc., 1976a) 
Rat  M, F  >8000  (Kolmar Research Center, 1972) 
Rat  M, F  >64000  (Bio-Toxicology Laboratories, 1982) 
Rat NR  >5000  (Moreno,  1978c) 
Sec-Butyl formate [09.328]  Rat  NR  11300  (Union Carbide Corp., 1980) 
9-Decen-2-one [07.262]  Rat  F  2500  (Flavour Industry, 2009m) 
(6-Methylhepta-3,5-dien-2-one [07.099])  Mouse  M, F  3200  (Colaianni, 1967) 
Pseudo-ionone [07.198]  Rat  NR  >5000  (Moreno, 1976b) 
NR: Not Reported. 
 
 Flavouring Group Evaluation 07, Revision 4
 
EFSA Journal 2012;10(10):2899  57
Subacute / subchronic / chronic toxicity data are available for three candidate substances and for ten supporting substances of the present flavouring group. 
They were evaluated at the 51
st and 59
th JECFA meetings (JECFA, 1999a; JECFA, 2003a). No carcinogenicity data are available. The supporting substances 
are listed in brackets.  
Table IV.2: Subacute, subchronic, chronic and carcinogenicity studies 
Chemical Name [FL-no]  Species;Sex  
No. per Group 
Route Dose  levels 
(mg/kg/day) 
Duration NOAEL 
(mg/kg/day) 
Reference Comments 
(Acetone [07.050])  Rat; M, F 
10 
Drinking water  0, 250, 500, 1000, 
2000, 5000  
13 weeks  1000 
1  (Dietz, 1991)  3  
NTP study. 
Mouse; M, F 
10 
Drinking water  0, 312.5, 625, 1250, 
2500, 5000 (M)  
0, 625, 1250, 2500, 
5000, 12500 (F) 
13 weeks  2500 
1  (Dietz, 1991)  3  
NTP study. 
Rat; M, F 
30 
Gavage  0, 100, 500, 2500  90 days  100  (Sonawane et al., 1986)  3  
Meeting abstract. 
Rat; NR 
3 
Drinking water  1000  4 weeks  1000
 1, 2  (Spencer et al., 1978) Examinations  were 
limited to specific 
neurotoxic effects. No 
other parameter was 
monitored. 
(Isopropyl alcohol [02.079])  Human; M 
8 
Oral  0, 2.6, 6.4  6 weeks  6.4 
2  (Wills et al., 1969)   3  
Paper published in a peer 
reviewed journal. 
Rat; M 
22 
Drinking water  0, 870, 1280, 1680, 
2520 
12 weeks  870  (Pilegaard and Ladefoged, 1993)  3  
Good quality study. 
Pentan-3-one [07.084]  Rat; F 
5 
Drinking water  0, 1860  120 days  Not detected 
(<1860) 
(Union Carbide Corp., 1977)  Good quality 
unpublished report. 
Focused on neurotoxic 
effect. 
(2-Heptanone [07.002])  Rat; M, F 
15 
Gavage (dissolved 
in corn oil) 
0, 20, 100, 500  13 weeks  20  (Gaunt et al., 1972a)  3  
Good quality study- 
peer-reviewed journal. 
Rat: NR 
5 
Drinking Water  0, 500  12 weeks  500 
1, 2  (Spencer et al., 1978)  3  
Good quality study- 
peer-reviewed journal. 
(3-Heptanone [07.003])  Rat; M 
2 
Gavage  0, 250, 500, 1000, 
2000, 4000 
14 weeks  1000  (O’Donoghue et al.,  1984)  3  
Good quality study- 
peer-reviewed journal. 
Rat; F 
NR 
Drinking Water  1000  120 days  1000 
1  (Homan and Maronpot, 1978)  3 
Meeting abstract. 
Rat; F 
5 
Drinking water  0, 27  120 days  27
2  (Union Carbide Corp., 1977)  Good quality 
unpublished report. 
Focused on neurotoxic 
effect. 
(4-Heptanone [07.058])  Rat; M 
8 
Gavage  0, 1000  90 days  not detected 
(<1000) 
(O’Donoghue and Krasavage, 1980)  3  
Good quality 
unpublished report. 
Rat; M 
3 
Gavage 
(undiluted) 
0, 1000, 2000, 4000  3 weeks  not detected 
(<1000) 
(Krasavage and O’Donoghue, 1979)  3  
Good quality Flavouring Group Evaluation 07, Revision 4
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Table IV.2: Subacute, subchronic, chronic and carcinogenicity studies 
Chemical Name [FL-no]  Species;Sex  
No. per Group 
Route Dose  levels 
(mg/kg/day) 
Duration NOAEL 
(mg/kg/day) 
Reference Comments 
unpublished report. 
(2-Nonanone [07.020])  Rat; M 
3 
Gavage 
(undiluted) 
0, 1000, 2000, 4000  3 weeks  not detected 
(<1000) 
(Krasavage and O’Donoghue, 1979)  3  
Good quality 
unpublished report. 
Rat; M 
8 
Gavage  0, 2000  90 days  not detected 
(<2000) 
(O’Donoghue and Krasavage, 1980)  3  
Good quality 
unpublished report. 
(4-Methyl-2-pentanone [07.017])  Rat; M, F 
5 
Drinking water  0, 1040  120 days  not detected 
(<1040)
 
(Union Carbide Corp., 1977)  Good quality 
unpublished report. 
Focused on neurotoxic 
effect. 
Rat; F 
NR 
Drinking water  1000  120 days  1000 
2  (Homan and Maronpot, 1978)  3  
Meeting abstract. 
Methyl-5-heptan-3-one [07.182]  Rat; M 
5 
Gavage (in 
distilled water) 
82, 410, 820   13 weeks  
(5 days/week) 
82  (IBM Corp., 1989)  Good quality 
unpublished Report -
submitted to EPA. 
(2,6-Dimethyl-4-heptanone [07.122])  Rat; M 
8 
Gavage  0, 2000  90 days  not detected 
(<2000) 
(O’Donoghue and Krasavage, 1980)  3  
Good quality 
unpublished report. 
(5-Methyl-5-hexen-2-one [07.100])  Rat; M, F 
5 
Diet 0,  10  14  days  10 
2  (Gill and Van Miller, 1987a)  4  
GLP study-unpublished 
report. 
(2,6,10-Trimethyl-2,6,10-pentadecatrien-
14-one [07.114]) 
Rat; M, F 
5 
Oral (gavage in 
maize oil) 
0, 0.35, 3.5  14 days  .3.5  (deGroot et al., 1974)  4  
TNO Unpublished 
Report.  
9-Decen-2-one [07.262]  Rat; M, F 
5 
Oral (gavage in 
corn oil) 
0, 250, 500, 1000  28 days  1000
5  (Flavour Industry, 2009m)   
NR = sex not reported; M = Male; F = Female 
1. Concentrations converted to mg/kg bw/day using conversion table for test chemical treatment doses used in PAFA (FDA, 1993).  
2. This study was performed at a single dose level that produced no adverse effects.  
3. Summarised by JECFA, 51
st meeting (JECFA, 1999a). 
4. Summarised by JECFA 59
th meeting (JECFA, 2003a). 
5. The highest dose tested. Flavouring Group Evaluation 07, Revision 4
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Developmental and reproductive toxicity data are available for two candidate substance of the present Flavouring Group Evaluation from chemical group 5 
and for one supporting substance evaluated by the JECFA at the 51
st meetings (JECFA, 1999a). The supporting substance is listed in brackets. 
Table IV.3: Developmental and Reproductive Toxicity Studies 
Chemical name [FL-no]  Study type/duration  Species/sex 
No/group 
Route NOAEL 
mg/kg/day including 
information on possible 
maternal toxicity 
Reference Comments 
(Isopropyl alcohol [02.079])  Reproductive Toxicity: 2 generations with 10 weeks 
of dosing prior to mating 
Rat; M, F 
4; 60 
Gavage  500  (Bevan et al., 1995)  EPA Guideline compliance. 
Developmental Toxicity: Gestation days 6-15  Rat; F 
4; 25 
Gavage 400  (maternal) 
400 (foetal) 
(Tyl et al., 1994)  1  
EPA Guideline compliance. 
Developmental Toxicity: Gestation days 6-18  Rabbit; F 
4; 15 
Gavage 240  (maternal) 
480 (foetal) 
(Tyl et al., 1994)  1  
EPA Guideline compliance. 
Pentan-3-one [07.084]  Fertility Screen: 28 daily doses with mating starting 
on day 10 
Mouse; F 
2; 8 
I.p.  50  (Hall et al., 1974)  Few details given in the paper. 
Pseudo-ionone [07.198]  Developmental Toxicity: Gestation days 8  Hamster; F 
3; 20 (control) 
and 7 or 10 
Oral 960  (Willhite,  1986)   
M = Male; F = Female. 
1. Summarised by JECFA, 51
st meeting (JECFA, 1999a). Flavouring Group Evaluation 07, Revision 4
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In vitro mutagenicity/genotoxicity data are available for nine candidate substances of the present flavouring group evaluation from chemical group 5 and for 
10 supporting substances evaluated at the 51
st and 59
th JECFA meetings. The supporting substances are listed in brackets. 
Table IV.4: Genotoxicity (in vitro) 
Chemical Name [FL-No.]  Test system  Test Object Concentration  Result  Reference  Comments 
(Acetone [07.050])  Rec assay  B. subtilis NR  Negative 
1 (Kawachi et al., 1980a)  8 
Rec assay  B. subtilis  NR  Negative  (Ishizaki et al., 1979)  8 
Ames test  S. typhimurium TA100  0.1 to 1000 µg/plate  Negative  (Rapson et al., 1980)  8 
Ames test  S. typhimurium TA98, TA100, TA1535, 
TA1537 
174 µg/plate  Negative 
1  (Florin et al., 1980)  8 
Ames test  S. typhimurium TA98, TA100  NR  Negative 
1  (Kawachi et al., 1980a)  8 
Ames test 
2  S. typhimurium TA98, TA100  30 µl/plate  Negative 
4 (Yamaguchi,  1985)  8 
Ames test  S. typhimurium TA97, TA98, TA100, 
TA1535, TA1537 
Up to 10000 µg/plate  Negative 
1  (McCann et al., 1975)  8 
Ames test 
2  S. typhimurium TA97, TA98, TA100, 
TA1535, TA1537 
Up to 10000 µg/plate  Negative 
1  (Zeiger et al., 1992)  8 
Ames test  S. typhimurium TA100  500 µg/plate  Negative 
1 (Yamaguchi,  1982)  8 
Ames test  S. typhimurium TA97, TA98, TA100  20 to 40 µg  Negative 
1  (Azizan and Blevins, 
1995) 
 
Sister chromatid exchange  Human embryo fibroblasts  NR  Negative 
4 (Kawachi et al., 1980a)  8 
Sister chromatid exchange  Hamster lung fibroblasts  NR  Negative 
4  (Kawachi et al., 1980a)  8 
Sister chromatid exchange  Chinese hamster ovary cells  Up to 10 µg/ml  Negative  (Sasaki et al., 1980)  8 
Sister chromatid exchange  Chinese hamster ovary cells  Up to 5020 µg/ml  Negative 
1  (Loveday et al., 1990)  8 
Sister chromatid exchange  Diploid human fibroblasts  5 µg/ml  Negative  (Sasaki et al., 1980)  8 
Sister chromatid exchange  Human lymphocytes  395 µg/ml  Negative  (Norppa et al., 1983)  8 
Sister chromatid exchange  Human lymphocytes  0.1 to 1 mM  Negative  (Zarani et al., 1999)  8 
Chromosomal aberrations  Chinese hamster ovary cells  Up to 5020 µg/ml  Negative 
1  (Loveday et al., 1990)  8 
Chromosomal aberrations  Hamster lung fibroblasts  NR  Positive 
4  (Kawachi et al., 1980a)  8 
Aneuploidy induction  S. cerevisiae 6.98-7.83  %  Positive 
4  (Zimmermann et al., 
1985a) 
11 
(Isopropyl alcohol [02.079])  Ames test  S. typhimurium TA98, TA100, TA1535, 
TA1537 
174 µg/plate  Negative 
1  (Florin et al., 1980)  8 
Ames test 
2  S. typhimurium TA98, TA100, TA1535, 
TA1537, E. coli WP2uvrA 
5 to 5000 µg/plate  Negative 
1  (Shimizu et al., 1985)  8 
Ames test 
2  S. typhimurium TA97, TA98, TA100, 
TA102, TA104, TA1535, TA1537 
Up to 10 mg/plate 
5 Negative 
1  (Zeiger et al., 1992)  8 
Forward mutation  Chinese hamster ovary cells 
6 0.5 to 5.0 mg/ml  Negative 
1 (CMA,  1990) 8 
Forward mutation  Chinese hamster ovary cells 
6 0.5 to 5.0 mg/ml  Negative 
1  (Kapp et al., 1993a)  8 
(2-Butanone [07.053])  Ames test  S. typhimurium TA98, TA100, TA1535, 
TA1537, TA1538 
10000 µg/plate  Negative 
1  (Douglas et al., 1980)  8 
Ames test  S. typhimurium TA102, TA104  1 mg/plate  Negative  (Marnett et al., 1985a)  8 
 Ames  test 
2  S. typhimurium TA98, TA100, TA1535, 
TA1537, TA1538 
5 to 5000 µg/plate  Negative 
1  (Shimizu et al., 1985)  8 
Ames test  S. typhimurium TA98, TA100, TA1535, 
TA1537, TA1538 
0.04 to 26 µg/plate  Negative 
1  (O’Donoghue et al., 
1988) 
8 
Ames test 
2  S. typhimurium TA97, TA98, TA100, 
TA104, TA1535, TA1537 
Up to 10000 µg/plate  Negative 
1  (Zeiger et al., 1992)  8 
Ames test  S. typhimurium TA102  5000 µg/plate  Negative 
4  (Müller et al., 1993)  8 
Ames test  S. typhimurium TA98, TA100, TA1535,  4000 µg/plate  Negative  (Brooks et al., 1988)  8 Flavouring Group Evaluation 07, Revision 4
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Table IV.4: Genotoxicity (in vitro) 
Chemical Name [FL-No.]  Test system  Test Object Concentration  Result  Reference  Comments 
TA1537, TA1538, E. coli WP2uvrA 
Gene conversion  S. cerevisiae 5  mg/ml  Negative 
1  (Brooks et al., 1988)  8 
Forward Mutation  L5178Y/TL+/- mouse lymphoma cells  0.67 to 12 µg/ml  Negative 
1  (O’Donoghue et al., 
1988) 
8 
Unscheduled DNA synthesis  Human lymphocytes  0.72 mg/ml  Negative 
1  (Perocco et al., 1983)  8 
Unscheduled DNA synthesis  Rat hepatocytes  7.2 to 360 mg/ml  Negative  (O’Donoghue et al., 
1988) 
8 
Chromosomal aberrations  Rat hepatocytes  1000 µg/ml  Negative  (Brooks et al., 1988)  8 
Chromosomal aberrations  Chinese hamster ovary cells  1000 µg/ml  Negative 
1  (Brooks et al., 1988)  8 
Cell transformation assay
1  BALB/3T3 cells (clone A31-1)  6-18 µl/ml  Negative  (O’Donoghue et al., 
1988) 
 
Aneuploidy induction  S. cerevisiae 3.38  %  Positive 
4  (Zimmermann et al., 
1985a) 
11 
Pentan-3-one [07.084]  Aneuploidy induction  S. cerevisiae 1.48  %  Positive 
4  (Zimmermann et al., 
1985a) 
11 
Pentan-3-ol [02.077]  Chromosomal aberrations  Chinese hamster ovary cells  0.5 to 10 %  Negative 
1  (Abbondandolo et al., 
1980) 
 
Forward mutation  S. pombe  0.5 to 10 %  Negative 
1  (Abbondandolo et al., 
1980) 
 
(2-Heptanone [07.002])  Unscheduled DNA synthesis  Rat hepatocytes  1000 ppm  Negative  (Barber et al., 1999)   
Methyl-3-butan-2-one 
[07.178] 
Aneuploidy induction  S. cerevisiae  1.23 to 1.36 %  Negative 
4  (Zimmermann et al., 
1985a) 
11 
Aneuploidy induction  S. cerevisiae  0.84 to 1.23 %  Negative 
4  (Zimmermann et al., 
1985a) 
11 
(4-Methyl-2-pentanone 
[07.017]) 
Ames test  S. typhimurium TA98, TA100, TA1535, 
TA1537, TA1538 
0.03 to 3 mg/plate  Negative 
1  (O’Donoghue et al., 
1988) 
8 
Ames test 
2  S. typhimurium TA97, TA98, TA100, 
TA1535 
Up to 6667 µg/plate  Negative 
1  (Zeiger et al., 1992)  8 
Ames test  E. coli WP2uvrA  8000 µg/plate  Negative 
4  (Brooks et al., 1988)  8 
Gene conversion  S. cerevisiae 5  mg/ml  Negative 
1  (Brooks et al., 1988)  8 
Forward mutation  L5178Y/TL+/- mouse lymphoma cells  0.26 to 4.2 µg/ml  Negative 
1  (O’Donoghue et al., 
1988) 
8 
Unscheduled DNA synthesis  Rat hepatocytes  8 to 80 µg/ml  Negative  (O’Donoghue et al., 
1988) 
8 
Chromosomal aberrations  Rat hepatocytes  1000 µg/ml  Negative  (Brooks et al., 1988)  8 
Cell transformation assay 
1  BALB/3T3 cells (clone A31-1)  1-7µl/ml  Negative  (O’Donoghue et al., 
1988) 
 
Chromosomal aberrations  Chinese hamster ovary cells  1000 µg/ml  Negative 
1  (Brooks et al., 1988)  8 
Methyl-4-pentan-2-ol [02.183]  Ames test 
2  S. typhimurium TA98, TA100, TA1535, 
TA1537, TA1538, E. coli WP2uvrA 
5000 µg  Negative 
1  (Shimizu et al., 1985)   
Methyl-6-heptan-2-one 
[07.181] 
Ames test  S. typhimurium TA98, TA100, TA1535, 
TA1537 
5000 µg/plate  Negative 
1 (BASF,  1989a)   
(2,6-Dimethyl-4-heptanone 
[07.122]) 
Ames test 
2  S. typhimurium TA98, TA100, TA1535, 
TA1537 
1 to 333 µg/plate  Negative 
1  (Mortelmans et al., 
1986) 
8 
Trimethyl-6,10,14-
pentadecan-2-one [07.205] 
Ames test  S. typhimurium TA98, TA100, TA1535, 
TA1537 
5000 µg/plate  Negative 
1 (BASF,  1989b)   
(6-Methyl-5-hepten-2-one 
[07.015]) 
Reverse mutation  S. typhimurium TA98, TA100, TA1535, 
TA1537 
380 µg/plate  Negative 
1  (Florin et al., 1980)  9 Flavouring Group Evaluation 07, Revision 4
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Table IV.4: Genotoxicity (in vitro) 
Chemical Name [FL-No.]  Test system  Test Object Concentration  Result  Reference  Comments 
(Isopropyl acetate [09.003])  Ames test 
2  S. typhimurium TA97, TA98, TA100, 
TA1537, TA1538 
Up to 10 mg/plate  Negative 
1  (Zeiger et al., 1992)  8 
(Isopropyl myristate [09.105])  Ames test 
7  S. typhimurium TA98, TA100, TA1535, 
TA1537, TA1538 
50 µg/plate  Negative 
1  (Blevins and Taylor, 
1982) 
8 
Isopropyl hexadecanoate 
[09.606] 
Ames test 
7  S. typhimurium TA98, TA100, TA1535, 
TA1537, TA1538 
50 µg/plate  Negative 
1  (Blevins and Taylor, 
1982) 
 
9-Decen-2-one [07.262]  Ames test
10  S. typhimurium TA98, TA100, TA1535, 
TA1537 
Up to 5 µL/plate  Negative
1 (Flavour  Industry, 
2009m) 
 
Ames test
10  E. coli WP2 (pKM 101)  Up to 5 µL/plate  Negative
1 (Flavour Industry, 
2009m) 
 
(6-Methylhepta-3,5-dien-2-
one [07.099]) 
Reverse mutation  S. typhimurium TA98, TA100, TA1535, 
TA1537 
370 µg/plate  Negative
1 (Florin et al., 1980)   
  Reverse Mutation  S. typhimurium TA98, TA100, TA1535, 
TA1537 and TA102 
1.6, 8, 40, 200, 1000 and 
5000 μg/plate   
Negative
1 (Williams, 2009a)  Toxicity observed in all strains at 2000 
μg/plate or greater in the absence of S9 
and at 800 μg/plate in the presence of 
S9. Study design complied with current 
recommendations. Acceptable top 
concentration was achieved. 
  Micronucleus induction  Human peripheral blood lymphocytes  225, 325 and 450 μg/ml 
13 
225, 300 and 350 μg/ml 
14 
Negative  (Whitwell, 2010a)  Complies with draft OECD guideline 
487. Acceptable levels of cytotoxicity 
achieved at the top concentrations used 
in all parts of the study. 
Pseudo-ionone [07.198]  Ames test  S. typhimurium TA98, TA100, TA1535, 
TA1537 
20.48, 51.2, 128, 320, 
800, 2000 and 5000 
μg/plate 
12 
Negative
1 (Florin et al., 1980)  9 
 Reverse  Mutation  S. typhimurium TA98, TA100, TA1535, 
TA1537 and TA102 
0.128, 0.64, 3.2, 16, 80, 
400 and 2000 μg/plate  
Negative
1 (Beevers, 2009a)  Toxicity was observed in all strains at 
400 μg/plate and greater in the presence 
and absence of S9 in this experiment. 
      0.12.5, 25, 50, 100, 200 
and 400 μg/plate 
12 
Negative
1   Precipitation was observed in the 400 
μg/plate concentration in the presence 
and absence of S9 in this experiment. 
Study design complies with current 
recommendations. Acceptable top 
concentrations were achieved. 
  Micronucleus induction  Human peripheral blood lymphocytes  30, 50 and 60 μg/ml
13 
100, 110 and 120 μg/ml
14 
Negative  (Lloyd, 2010a)  Complies with draft OECD guideline 
487. Acceptable levels of cytotoxicity 
achieved at the top concentrations used 
in all parts of the study. 
  Micronucleus induction  Human peripheral blood lymphocytes  10, 15 and 20 μg/ml
15  Negative  (Lloyd, 2010a)  Complies with draft OECD Guideline 
487. Acceptable levels of cytotoxicity 
achieved at the top concentrations used 
in all parts of the study. 
1. Assay performed with and without metabolic activation. 
2. Modified Ames (Pre-incubation) protocol. 
3. Assay performed with S9 metabolic activation. 
4. Assay performed without S9 metabolic activation. 
5. Maximum non-toxic dose. 
6. HGPRT locus. Flavouring Group Evaluation 07, Revision 4
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7. Spot test. 
8. Summarised by JECFA, 51
st meeting (JECFA, 1999a). 
9. Summarised by JECFA 59
th meeting (JECFA, 2003a). 
10. Direct incorporation method. 
11. Unusual experimental protocol for detection of aneuploidy, which can be considered a threshold effect not mediated by a direct interaction with DNA. Positive results were obtained at 
concentrations approaching cytotoxic levels and are very likely due to the presence of technical artefacts (low temperature treatment inducing tubulin dissociation). Indeed, absence of effect 
was recorded when the ice treatment was skipped. – The limited relevance of fungal systems together with the uncertain quality of these results make questionable their extrapolation to the 
in vivo situation in humans. 
12. Assay modified with pre-incubation in the presence of S9. 
13. Without metabolic activation, 3 hours treatment + 21 hours recovery. 
14. With metabolic activation, 3 hours treatment + 21 hours recovery. 
15. Without metabolic activation, 24 hours + 0 hours recovery. 
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In vivo mutagenicity / genotoxicity data available for four supporting substances evaluated at the 51
st and 59
th JECFA meetings. The supporting substances are 
listed in brackets. 
Table IV.5: Genotoxicity Studies (In Vivo) 
Chemical Name  Test system  Test Object Route  Dose  Result  Reference  Comments 
(Isopropyl alcohol [02.079])  Micronucleus test   ICR Mouse (15M & 15F)   i.p. injection in 0.9% NaCl  350-2500 mg/kg  Negative  (Kapp et al., 1993a)  1 
(Acetone [07.050])  Micronucleus test  Chinese hamster (5M & 5F)  i.p. injection in corn oil  865 mg/kg  Negative  (Basler, 1986)  1 
(2-Butanone [07.053])  Micronucleus test  CD-1 mice (5M & 5F)  i.p. injection in corn oil  LD20 (1.96 ml/kg)  Negative  (O’Donoghue et al., 1988)  1 
Micronucleus test  Chinese hamster (5M & 5F)  i.p. injection in corn oil  411mg/kg  Negative  (Basler, 1986)  1 
(4-Methyl-2-pentanone 
[07.017]) 
Micronucleus test  CD-1 mice (5M & 5F)  i.p. injection in corn oil  LD20 (0.73 ml/kg)  Negative  (Basler, 1986)  1 
1. Summarised by JECFA, 51
st meeting (JECFA, 1999a). Flavouring Group Evaluation 07, Revision 4
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ABBREVIATIONS 
ADI   Acceptable  Daily  Intake 
AUC   Area  Under  Curve 
BW   Body  Weight 
CAS    Chemical Abstract Service 
CEF  Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
Chemical Abstract Service 
CHO    Chinese hamster ovary (cells) 
CoE    Council of Europe 
DNA   Deoxyribonucleic  acid 
EC   European  Commission 
EFFA    European Flavour and Fragrance Association 
EFSA    The European Food Safety Authority 
EU   European  Union 
FAO    Food and Agriculture Organization of the United Nations  
FEMA    Flavor and Extract Manufacturers Association 
FGE    Flavouring Group Evaluation  
FLAVIS (FL)  Flavour Information System (database) 
FOB    Functional Observational Battery 
HGPRT Hypoxanthine-Guanine PhosphoRibosylTransferase 
ID     Identity 
IOFI   International  Organization of the Flavour Industry 
IP     IntraPeritoneal 
IR     Infrared spectroscopy 
JECFA   The Joint FAO/WHO Expert Committee on Food Additives 
LD50   Lethal Dose, 50%; Median lethal dose 
MS   Mass  spectrometry 
MSDI    Maximised Survey-derived Daily Intake 
mTAMDI  Modified Theoretical Added Maximum Daily Intake 
NAD    Nicotinamide Adenine Dinucleotide  
NADH   Nicotinamide Adenine Dinucleotide – reduced form 
NADP   Nicotinamide  Adenine Dinucleotide Phosphate 
NADPH  Nicotinamide Adenine Dinucleotide Phosphate – reduced form 
No     Number 
NOAEL  No Observed Adverse Effect Level 
NOEL    No Observed Effect Level Flavouring Group Evaluation 07, Revision 4
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NTP    National Toxicology Program 
SCE    Sister Chromatid Exchange 
SCF    Scientific Committee on Food 
SMART   Somatic Mutation and Recombination Test  
TAMDI  Theoretical Added Maximum Daily Intake 
UGAC   Average Urinary Output of Glucuronide   
UDS    Unscheduled DNA Synthesis  
WHO    World Health Organisation  
 